activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1824462	CHEMBL913830	Inhibition of Cdc42BPA	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	Ki	uM	10.0
	1824462	CHEMBL913830	Inhibition of Cdc42BPA	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	Ki	uM	10.0
	1824581	CHEMBL913830	Inhibition of Cdc42BPA	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	=	Ki	nM	4440.0	CHEMBL4516	Homo sapiens	Ki	uM	4.44
	1824698	CHEMBL913830	Inhibition of Cdc42BPA	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	=	Ki	nM	6630.0	CHEMBL4516	Homo sapiens	Ki	uM	6.63
	2051598	CHEMBL942739	Inhibition of CDC42BPA	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	9524.0	CHEMBL4516	Homo sapiens	Ki	uM	9.524
	2147316	CHEMBL922001	Activity of human MRCKalpha kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	101.0	CHEMBL4516	Homo sapiens	Activity	%	101.0
	2470279	CHEMBL987198	Inhibition of MRCKA at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4516	Homo sapiens	INH	%	10.0
Not Evaluated	2476704	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4516	Homo sapiens	Activity		
Not Evaluated	2478543	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4516	Homo sapiens	Activity		
Not Evaluated	2478746	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL4516	Homo sapiens	Activity		
	2479601	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	8.1	CHEMBL4516	Homo sapiens	Activity	%	8.1
Not Evaluated	2479804	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL4516	Homo sapiens	Activity		
Not Evaluated	2480601	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL4516	Homo sapiens	Activity		
Not Evaluated	2480803	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL4516	Homo sapiens	Activity		
	2505360	CHEMBL943653	Inhibition of MRCKalpha	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2C1		CHEMBL474425	=	IC50	nM	210.0	CHEMBL4516	Homo sapiens	IC50	nM	210.0
	2505365	CHEMBL943653	Inhibition of MRCKalpha	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccc(F)cc2C1		CHEMBL481545	=	IC50	nM	79.0	CHEMBL4516	Homo sapiens	IC50	nM	79.0
	2505366	CHEMBL943653	Inhibition of MRCKalpha	B	COc1ccc2c(c1)CC(C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCN(C)C)CO2		CHEMBL482336	=	IC50	nM	150.0	CHEMBL4516	Homo sapiens	IC50	nM	150.0
	2512023	CHEMBL970572	Inhibition of MRCKalpha at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	11.0	CHEMBL4516	Homo sapiens	INH	%	11.0
	2567263	CHEMBL975450	Inhibition of human MRCKalpha kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	98.0	CHEMBL4516	Homo sapiens	Activity	%	98.0
Not Evaluated	2577222	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4516	Homo sapiens	Activity		
Not Evaluated	2577425	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4516	Homo sapiens	Activity		
Not Evaluated	2593630	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4516	Homo sapiens	Activity		
Not Evaluated	2593896	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL4516	Homo sapiens	Activity		
Not Evaluated	2594099	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4516	Homo sapiens	Activity		
Not Evaluated	2594839	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4516	Homo sapiens	Activity		
Not Evaluated	2595042	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4516	Homo sapiens	Activity		
Not Evaluated	2596239	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4516	Homo sapiens	Activity		
Not Evaluated	2596442	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4516	Homo sapiens	Activity		
Not Evaluated	2597711	CHEMBL982732	Binding affinity to human MRCKA at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4516	Homo sapiens	Activity		
	2721656	CHEMBL1057485	Inhibition of MRCKalpha at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	2901619	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901620	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901621	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901622	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901623	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	9400.0	CHEMBL4516	Homo sapiens	Kd	nM	9400.0
	2901624	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901625	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901626	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901627	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901628	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901629	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901630	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	2000.0	CHEMBL4516	Homo sapiens	Kd	nM	2000.0
	2901631	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901632	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901633	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	9500.0	CHEMBL4516	Homo sapiens	Kd	nM	9500.0
	2901634	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901635	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901636	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901637	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901638	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901639	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901640	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901641	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901642	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901643	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Kd	nM	1800.0	CHEMBL4516	Homo sapiens	Kd	nM	1800.0
	2901644	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901645	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901646	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901647	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901648	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	6200.0	CHEMBL4516	Homo sapiens	Kd	nM	6200.0
	2901649	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901650	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901651	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	57.0	CHEMBL4516	Homo sapiens	Kd	nM	57.0
	2901652	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901653	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901654	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901655	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	2901656	CHEMBL1060251	Binding constant for MRCKA kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2600.0	CHEMBL4516	Homo sapiens	Kd	nM	2600.0
	2921258	CHEMBL1048280	Inhibition of MRCKA assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	87.0	CHEMBL4516	Homo sapiens	Activity	%	87.0
	3213973	CHEMBL1116721	Inhibition of MRCKalpha at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	-2.0	CHEMBL4516	Homo sapiens	INH	%	-2.0
	3215582	CHEMBL1099848	Inhibition of MRCKalpha	B	CN(C)CCCNC(=O)c1ccc2c(c1)CC(c1nc3ccc(-c4cn[nH]c4)cc3s1)CO2		CHEMBL1079921	=	IC50	nM	9552.0	CHEMBL4516	Homo sapiens	IC50	nM	9552.0
	3215583	CHEMBL1099848	Inhibition of MRCKalpha	B	CCN(Cc1cccc(OC)c1)C(=O)c1nc2ccc(-c3cn[nH]c3)cc2s1		CHEMBL1081196	=	IC50	nM	7861.0	CHEMBL4516	Homo sapiens	IC50	nM	7861.0
	3215584	CHEMBL1099848	Inhibition of MRCKalpha	B	COc1cccc(CN(CCN(C)C)C(=O)c2nc3ccc(-c4cn[nH]c4)cc3s2)c1		CHEMBL1080279	=	IC50	nM	247.0	CHEMBL4516	Homo sapiens	IC50	nM	247.0
	3224773	CHEMBL1102615	Inhibition of MRCKalpha at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	3225023	CHEMBL1102615	Inhibition of MRCKalpha at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	3240793	CHEMBL1109656	Inhibition of CDC42BPA	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	3332038	CHEMBL1166576	Inhibition of MRCKA at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	3333453	CHEMBL1166576	Inhibition of MRCKA at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	3334858	CHEMBL1166576	Inhibition of MRCKA at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	3336278	CHEMBL1166576	Inhibition of MRCKA at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	3337588	CHEMBL1166576	Inhibition of MRCKA at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	3338919	CHEMBL1166576	Inhibition of MRCKA at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	3339172	CHEMBL1166576	Inhibition of MRCKA at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	3340475	CHEMBL1166576	Inhibition of MRCKA at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	3341820	CHEMBL1166576	Inhibition of MRCKA at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	3343267	CHEMBL1166576	Inhibition of MRCKA at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	3358681	CHEMBL1174923	Inhibition of MRCKA at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	87.0	CHEMBL4516	Homo sapiens	INH	%	87.0
	3359123	CHEMBL1174923	Inhibition of MRCKA at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	73.0	CHEMBL4516	Homo sapiens	INH	%	73.0
	3406823	CHEMBL1219256	Inhibition of MRCKalpha	B	CCN1Cc2ccccc2C[C@@H]1C(=O)Nc1cc(F)c(-c2cn[nH]c2)cc1OCCN(C)C		CHEMBL1215526	=	IC50	nM	810.0	CHEMBL4516	Homo sapiens	IC50	nM	810.0
	3406829	CHEMBL1219256	Inhibition of MRCKalpha	B	COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCC1CCN(C)CC1)NC2		CHEMBL1215304	=	IC50	nM	669.0	CHEMBL4516	Homo sapiens	IC50	nM	669.0
	3406839	CHEMBL1219256	Inhibition of MRCKalpha	B	CN(C)CCOc1cc(-c2cn[nH]c2)c(F)cc1NC(=O)[C@H]1Cc2ccccc2CN1		CHEMBL1215524	=	IC50	nM	333.0	CHEMBL4516	Homo sapiens	IC50	nM	333.0
	3408032	CHEMBL1219256	Inhibition of MRCKalpha	B	COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCN(C)C)NC2		CHEMBL1215171	=	IC50	nM	5350.0	CHEMBL4516	Homo sapiens	IC50	nM	5350.0
	3443354	CHEMBL1244387	Inhibition of MRCKalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	4.0	CHEMBL4516	Homo sapiens	INH	%	4.0
	3443571	CHEMBL1244387	Inhibition of MRCKalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	-4.0	CHEMBL4516	Homo sapiens	INH	%	-4.0
	3444726	CHEMBL1244387	Inhibition of MRCKalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	0.0	CHEMBL4516	Homo sapiens	INH	%	0.0
	3445350	CHEMBL1244387	Inhibition of MRCKalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	1.0	CHEMBL4516	Homo sapiens	INH	%	1.0
	3445567	CHEMBL1244387	Inhibition of MRCKalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	-1.0	CHEMBL4516	Homo sapiens	INH	%	-1.0
	3448514	CHEMBL1244522	Binding affinity to MRCKA	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	3449745	CHEMBL1244522	Binding affinity to MRCKA	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	3449938	CHEMBL1244522	Binding affinity to MRCKA	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	3450148	CHEMBL1244522	Binding affinity to MRCKA	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	3450365	CHEMBL1244522	Binding affinity to MRCKA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	3450806	CHEMBL1244522	Binding affinity to MRCKA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	3451063	CHEMBL1244522	Binding affinity to MRCKA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	uM	10.0
	3463187	CHEMBL1251726	Inhibition of CDC42 binding protein alpha at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	93.0	CHEMBL4516	Homo sapiens	INH	%	93.0
	3463406	CHEMBL1251726	Inhibition of CDC42 binding protein alpha at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	-3.0	CHEMBL4516	Homo sapiens	INH	%	-3.0
	3463950	CHEMBL1251726	Inhibition of CDC42 binding protein alpha at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	19.0	CHEMBL4516	Homo sapiens	INH	%	19.0
	3508195	CHEMBL1261693	Binding affinity to MRCKA at 10 uM relative to control	B	CCC(=O)N1CCN(c2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc2C(F)(F)F)CC1		CHEMBL1256459	=	Activity	%	0.65	CHEMBL4516	Homo sapiens	Activity	%	0.65
	3508196	CHEMBL1261694	Binding affinity to MRCKA	B	CCC(=O)N1CCN(c2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnc7ccccc7c6)cc5c43)cc2C(F)(F)F)CC1		CHEMBL1256459	=	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	5120371	CHEMBL1646203	Inhibition of human MRCKalpha at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	105.0	CHEMBL4516	Homo sapiens	INH	%	105.0
Not Active	5246579	CHEMBL1686698	Inhibition of MRCKalpha at 20 uM	B	COc1ccc2c(c1)CC(c1nc3ccc(-c4cn[nH]c4)cc3c(=O)[nH]1)CO2		CHEMBL1684200		Inhibition	%		CHEMBL4516	Homo sapiens	INH		
Not Active	5246580	CHEMBL1686698	Inhibition of MRCKalpha at 20 uM	B	O=C(c1ccc2c(c1)CC(c1nc3ccc(-c4cn[nH]c4)cc3c(=O)[nH]1)CO2)C1CC1		CHEMBL1684205		Inhibition	%		CHEMBL4516	Homo sapiens	INH		
	6340925	CHEMBL1826949	Activity of MRCKA kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	91.0	CHEMBL4516	Homo sapiens	Activity	%	91.0
	7567315	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7567774	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7568271	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	1300.0	CHEMBL4516	Homo sapiens	Kd	nM	1300.0
	7568703	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7569288	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7569748	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7569778	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7570241	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7570668	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7571264	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7571755	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7572218	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Kd	nM	1800.0	CHEMBL4516	Homo sapiens	Kd	nM	1800.0
	7572634	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7573260	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	2000.0	CHEMBL4516	Homo sapiens	Kd	nM	2000.0
	7573736	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7574205	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7574613	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7574781	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7575242	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7575713	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7576178	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7576586	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7576755	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7577214	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	660.0	CHEMBL4516	Homo sapiens	Kd	nM	660.0
	7577692	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7578162	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7578567	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2600.0	CHEMBL4516	Homo sapiens	Kd	nM	2600.0
	7578763	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	380.0	CHEMBL4516	Homo sapiens	Kd	nM	380.0
	7579137	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	9400.0	CHEMBL4516	Homo sapiens	Kd	nM	9400.0
	7579587	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	9500.0	CHEMBL4516	Homo sapiens	Kd	nM	9500.0
	7580061	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7581121	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7581506	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7581951	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7582422	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7582444	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7582844	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7583467	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7583864	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7584309	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7584800	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7585204	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7585797	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7586205	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7586680	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7587134	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7587758	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7588188	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7588659	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7589110	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	6200.0	CHEMBL4516	Homo sapiens	Kd	nM	6200.0
	7589705	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	9200.0	CHEMBL4516	Homo sapiens	Kd	nM	9200.0
	7590172	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7590646	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7591097	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7591254	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7591676	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7592148	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7592621	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7593074	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7593221	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7593656	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7594128	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7594601	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7595053	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7595189	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7595633	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7596107	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7596578	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7597161	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7597614	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7598087	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4516	Homo sapiens	Kd	nM	10000.0
	7598557	CHEMBL1908617	Binding constant for MRCKA kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	57.0	CHEMBL4516	Homo sapiens	Kd	nM	57.0
Not Active	7950033	CHEMBL1924572	Inhibition of MRCKalpha at 5 uM	B	COc1cccc(CNC(=O)c2cc3ccc(-c4cn[nH]c4)nc3n2CCN(C)C)c1		CHEMBL1922038		Inhibition	%		CHEMBL4516	Homo sapiens	INH		
Not Active	7950034	CHEMBL1924572	Inhibition of MRCKalpha at 5 uM	B	COc1cccc(CNC(=O)c2cc3ccc(-c4cn[nH]c4)nc3n2CCCO)c1		CHEMBL1922039		Inhibition	%		CHEMBL4516	Homo sapiens	INH		
	8061223	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.67	CHEMBL4516	Homo sapiens	Inhibition	%	0.67
	8061400	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-1.07	CHEMBL4516	Homo sapiens	Inhibition	%	-1.07
	8061624	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.16	CHEMBL4516	Homo sapiens	Inhibition	%	-0.16
	8061731	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	10.68	CHEMBL4516	Homo sapiens	Inhibition	%	10.68
	8062146	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.55	CHEMBL4516	Homo sapiens	Inhibition	%	0.55
	8062262	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.33	CHEMBL4516	Homo sapiens	Inhibition	%	1.33
	8062648	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	0.72	CHEMBL4516	Homo sapiens	Inhibition	%	0.72
	8062970	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.14	CHEMBL4516	Homo sapiens	Inhibition	%	0.14
	8063102	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.06	CHEMBL4516	Homo sapiens	Inhibition	%	-0.06
	8063493	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.43	CHEMBL4516	Homo sapiens	Inhibition	%	3.43
	8063601	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.14	CHEMBL4516	Homo sapiens	Inhibition	%	0.14
	8063825	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.49	CHEMBL4516	Homo sapiens	Inhibition	%	2.49
	8064007	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.13	CHEMBL4516	Homo sapiens	Inhibition	%	0.13
	8064122	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	10.32	CHEMBL4516	Homo sapiens	Inhibition	%	10.32
	8064346	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	7.29	CHEMBL4516	Homo sapiens	Inhibition	%	7.29
	8064556	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.14	CHEMBL4516	Homo sapiens	Inhibition	%	1.14
	8064694	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.45	CHEMBL4516	Homo sapiens	Inhibition	%	0.45
	8064918	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.02	CHEMBL4516	Homo sapiens	Inhibition	%	2.02
	8065084	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.51	CHEMBL4516	Homo sapiens	Inhibition	%	0.51
	8065424	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	0.43	CHEMBL4516	Homo sapiens	Inhibition	%	0.43
	8065599	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.81	CHEMBL4516	Homo sapiens	Inhibition	%	0.81
	8065938	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	53.42	CHEMBL4516	Homo sapiens	Inhibition	%	53.42
	8066148	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.8	CHEMBL4516	Homo sapiens	Inhibition	%	0.8
	8066508	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.39	CHEMBL4516	Homo sapiens	Inhibition	%	0.39
	8066674	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	3.19	CHEMBL4516	Homo sapiens	Inhibition	%	3.19
	8067022	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	0.85	CHEMBL4516	Homo sapiens	Inhibition	%	0.85
	8067197	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.58	CHEMBL4516	Homo sapiens	Inhibition	%	0.58
	8067542	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.08	CHEMBL4516	Homo sapiens	Inhibition	%	1.08
	8067752	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.36	CHEMBL4516	Homo sapiens	Inhibition	%	1.36
	8068111	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.14	CHEMBL4516	Homo sapiens	Inhibition	%	3.14
	8068275	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.38	CHEMBL4516	Homo sapiens	Inhibition	%	0.38
	8068499	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.09	CHEMBL4516	Homo sapiens	Inhibition	%	2.09
	8068624	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.16	CHEMBL4516	Homo sapiens	Inhibition	%	0.16
	8068798	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-0.35	CHEMBL4516	Homo sapiens	Inhibition	%	-0.35
	8069022	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.19	CHEMBL4516	Homo sapiens	Inhibition	%	0.19
	8069147	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	3.93	CHEMBL4516	Homo sapiens	Inhibition	%	3.93
	8069442	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	2.56	CHEMBL4516	Homo sapiens	Inhibition	%	2.56
	8069827	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.98	CHEMBL4516	Homo sapiens	Inhibition	%	0.98
	8069953	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.05	CHEMBL4516	Homo sapiens	Inhibition	%	-0.05
	8070349	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.36	CHEMBL4516	Homo sapiens	Inhibition	%	1.36
	8070474	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.14	CHEMBL4516	Homo sapiens	Inhibition	%	-0.14
	8070698	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.28	CHEMBL4516	Homo sapiens	Inhibition	%	-0.28
	8070772	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	21.55	CHEMBL4516	Homo sapiens	Inhibition	%	21.55
	8071153	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.69	CHEMBL4516	Homo sapiens	Inhibition	%	2.69
	8071279	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.34	CHEMBL4516	Homo sapiens	Inhibition	%	0.34
	8071503	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.69	CHEMBL4516	Homo sapiens	Inhibition	%	0.69
	8071676	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.4	CHEMBL4516	Homo sapiens	Inhibition	%	0.4
	8072025	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.38	CHEMBL4516	Homo sapiens	Inhibition	%	-0.38
	8072106	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.22	CHEMBL4516	Homo sapiens	Inhibition	%	0.22
	8072115	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.87	CHEMBL4516	Homo sapiens	Inhibition	%	0.87
	8072339	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.69	CHEMBL4516	Homo sapiens	Inhibition	%	0.69
	8072496	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.11	CHEMBL4516	Homo sapiens	Inhibition	%	1.11
	8072845	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.01	CHEMBL4516	Homo sapiens	Inhibition	%	0.01
	8073012	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-0.6	CHEMBL4516	Homo sapiens	Inhibition	%	-0.6
	8073361	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-1.54	CHEMBL4516	Homo sapiens	Inhibition	%	-1.54
	8073704	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.3	CHEMBL4516	Homo sapiens	Inhibition	%	1.3
	8073937	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.53	CHEMBL4516	Homo sapiens	Inhibition	%	2.53
	8074089	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.26	CHEMBL4516	Homo sapiens	Inhibition	%	3.26
	8074443	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.75	CHEMBL4516	Homo sapiens	Inhibition	%	0.75
	8074600	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.16	CHEMBL4516	Homo sapiens	Inhibition	%	0.16
	8074824	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-0.52	CHEMBL4516	Homo sapiens	Inhibition	%	-0.52
	8074951	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.06	CHEMBL4516	Homo sapiens	Inhibition	%	-0.06
	8075286	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.19	CHEMBL4516	Homo sapiens	Inhibition	%	1.19
	8075523	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.11	CHEMBL4516	Homo sapiens	Inhibition	%	0.11
	8075664	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.43	CHEMBL4516	Homo sapiens	Inhibition	%	1.43
	8075888	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.38	CHEMBL4516	Homo sapiens	Inhibition	%	4.38
	8076030	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.19	CHEMBL4516	Homo sapiens	Inhibition	%	-0.19
	8076402	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.17	CHEMBL4516	Homo sapiens	Inhibition	%	1.17
	8076536	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	4.44	CHEMBL4516	Homo sapiens	Inhibition	%	4.44
	8076862	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.33	CHEMBL4516	Homo sapiens	Inhibition	%	1.33
	8077109	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	29.02	CHEMBL4516	Homo sapiens	Inhibition	%	29.02
	8077461	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.21	CHEMBL4516	Homo sapiens	Inhibition	%	0.21
	8077612	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	2.79	CHEMBL4516	Homo sapiens	Inhibition	%	2.79
	8077979	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.94	CHEMBL4516	Homo sapiens	Inhibition	%	2.94
	8078118	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.79	CHEMBL4516	Homo sapiens	Inhibition	%	-0.79
	8078342	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.17	CHEMBL4516	Homo sapiens	Inhibition	%	0.17
	8078444	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.01	CHEMBL4516	Homo sapiens	Inhibition	%	1.01
	8078694	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	72.78	CHEMBL4516	Homo sapiens	Inhibition	%	72.78
	8079034	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.76	CHEMBL4516	Homo sapiens	Inhibition	%	2.76
	8079192	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.35	CHEMBL4516	Homo sapiens	Inhibition	%	-0.35
	8079416	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	4.31	CHEMBL4516	Homo sapiens	Inhibition	%	4.31
	8079558	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.13	CHEMBL4516	Homo sapiens	Inhibition	%	0.13
	8079921	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.45	CHEMBL4516	Homo sapiens	Inhibition	%	2.45
	8080026	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.89	CHEMBL4516	Homo sapiens	Inhibition	%	1.89
	8080250	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.28	CHEMBL4516	Homo sapiens	Inhibition	%	0.28
	8080278	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	3.02	CHEMBL4516	Homo sapiens	Inhibition	%	3.02
	8080502	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	6.98	CHEMBL4516	Homo sapiens	Inhibition	%	6.98
	8080617	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.54	CHEMBL4516	Homo sapiens	Inhibition	%	0.54
	8081005	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.35	CHEMBL4516	Homo sapiens	Inhibition	%	0.35
	8081140	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.47	CHEMBL4516	Homo sapiens	Inhibition	%	-0.47
	8081364	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.19	CHEMBL4516	Homo sapiens	Inhibition	%	0.19
	8081508	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	30.45	CHEMBL4516	Homo sapiens	Inhibition	%	30.45
	8081835	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.73	CHEMBL4516	Homo sapiens	Inhibition	%	3.73
	8082087	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	18.55	CHEMBL4516	Homo sapiens	Inhibition	%	18.55
	8082200	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.68	CHEMBL4516	Homo sapiens	Inhibition	%	2.68
	8082424	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.47	CHEMBL4516	Homo sapiens	Inhibition	%	1.47
	8082597	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.58	CHEMBL4516	Homo sapiens	Inhibition	%	2.58
	8082944	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.56	CHEMBL4516	Homo sapiens	Inhibition	%	0.56
	8083100	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	0.3	CHEMBL4516	Homo sapiens	Inhibition	%	0.3
	8083423	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.58	CHEMBL4516	Homo sapiens	Inhibition	%	1.58
	8083677	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	65.92	CHEMBL4516	Homo sapiens	Inhibition	%	65.92
	8084011	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.4	CHEMBL4516	Homo sapiens	Inhibition	%	1.4
	8084196	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	1.68	CHEMBL4516	Homo sapiens	Inhibition	%	1.68
	8084538	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	-0.16	CHEMBL4516	Homo sapiens	Inhibition	%	-0.16
	8084699	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	7.89	CHEMBL4516	Homo sapiens	Inhibition	%	7.89
	8084923	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.05	CHEMBL4516	Homo sapiens	Inhibition	%	2.05
	8085021	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.47	CHEMBL4516	Homo sapiens	Inhibition	%	2.47
	8085277	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.44	CHEMBL4516	Homo sapiens	Inhibition	%	1.44
	8085609	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.81	CHEMBL4516	Homo sapiens	Inhibition	%	0.81
	8085798	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	13.49	CHEMBL4516	Homo sapiens	Inhibition	%	13.49
	8086022	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.96	CHEMBL4516	Homo sapiens	Inhibition	%	0.96
	8086137	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.83	CHEMBL4516	Homo sapiens	Inhibition	%	0.83
	8086523	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	21.59	CHEMBL4516	Homo sapiens	Inhibition	%	21.59
	8086622	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.72	CHEMBL4516	Homo sapiens	Inhibition	%	1.72
	8086846	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.13	CHEMBL4516	Homo sapiens	Inhibition	%	1.13
	8087057	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.78	CHEMBL4516	Homo sapiens	Inhibition	%	1.78
	8087215	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.0	CHEMBL4516	Homo sapiens	Inhibition	%	0.0
	8087553	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-5.48	CHEMBL4516	Homo sapiens	Inhibition	%	-5.48
	8087691	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-3.23	CHEMBL4516	Homo sapiens	Inhibition	%	-3.23
	8087915	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-3.2	CHEMBL4516	Homo sapiens	Inhibition	%	-3.2
	8088057	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	7.84	CHEMBL4516	Homo sapiens	Inhibition	%	7.84
	8088429	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.21	CHEMBL4516	Homo sapiens	Inhibition	%	0.21
	8088557	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.42	CHEMBL4516	Homo sapiens	Inhibition	%	1.42
	8088874	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	10.89	CHEMBL4516	Homo sapiens	Inhibition	%	10.89
	8089226	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-1.24	CHEMBL4516	Homo sapiens	Inhibition	%	-1.24
	8089374	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.91	CHEMBL4516	Homo sapiens	Inhibition	%	1.91
	8089718	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.23	CHEMBL4516	Homo sapiens	Inhibition	%	-0.23
	8089898	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-4.53	CHEMBL4516	Homo sapiens	Inhibition	%	-4.53
	8090122	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-2.3	CHEMBL4516	Homo sapiens	Inhibition	%	-2.3
	8090287	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.12	CHEMBL4516	Homo sapiens	Inhibition	%	5.12
	8090454	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	6.14	CHEMBL4516	Homo sapiens	Inhibition	%	6.14
	8090678	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.64	CHEMBL4516	Homo sapiens	Inhibition	%	2.64
	8090817	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-5.74	CHEMBL4516	Homo sapiens	Inhibition	%	-5.74
	8091022	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	-0.82	CHEMBL4516	Homo sapiens	Inhibition	%	-0.82
	8091383	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	5.2	CHEMBL4516	Homo sapiens	Inhibition	%	5.2
	8091538	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.8	CHEMBL4516	Homo sapiens	Inhibition	%	1.8
	8091762	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.92	CHEMBL4516	Homo sapiens	Inhibition	%	1.92
	8091878	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-2.78	CHEMBL4516	Homo sapiens	Inhibition	%	-2.78
	8092239	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.87	CHEMBL4516	Homo sapiens	Inhibition	%	-1.87
	8092390	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.36	CHEMBL4516	Homo sapiens	Inhibition	%	2.36
	8092762	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.75	CHEMBL4516	Homo sapiens	Inhibition	%	1.75
	8092891	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	0.91	CHEMBL4516	Homo sapiens	Inhibition	%	0.91
	8093115	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.38	CHEMBL4516	Homo sapiens	Inhibition	%	-0.38
	8093203	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.26	CHEMBL4516	Homo sapiens	Inhibition	%	0.26
	8093567	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	12.01	CHEMBL4516	Homo sapiens	Inhibition	%	12.01
	8093706	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	3.43	CHEMBL4516	Homo sapiens	Inhibition	%	3.43
	8093930	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.42	CHEMBL4516	Homo sapiens	Inhibition	%	1.42
	8094050	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.6	CHEMBL4516	Homo sapiens	Inhibition	%	1.6
	8094454	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-3.4	CHEMBL4516	Homo sapiens	Inhibition	%	-3.4
	8094629	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	9.71	CHEMBL4516	Homo sapiens	Inhibition	%	9.71
	8095009	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.17	CHEMBL4516	Homo sapiens	Inhibition	%	2.17
	8095149	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.82	CHEMBL4516	Homo sapiens	Inhibition	%	-0.82
	8095352	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	-2.61	CHEMBL4516	Homo sapiens	Inhibition	%	-2.61
	8095576	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.79	CHEMBL4516	Homo sapiens	Inhibition	%	0.79
	8095717	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	9.75	CHEMBL4516	Homo sapiens	Inhibition	%	9.75
	8096089	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.94	CHEMBL4516	Homo sapiens	Inhibition	%	0.94
	8096206	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	-3.17	CHEMBL4516	Homo sapiens	Inhibition	%	-3.17
	8096430	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	0.21	CHEMBL4516	Homo sapiens	Inhibition	%	0.21
	8096569	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-2.24	CHEMBL4516	Homo sapiens	Inhibition	%	-2.24
	8096725	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	5.45	CHEMBL4516	Homo sapiens	Inhibition	%	5.45
	8096949	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.16	CHEMBL4516	Homo sapiens	Inhibition	%	3.16
	8097096	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.49	CHEMBL4516	Homo sapiens	Inhibition	%	2.49
	8097403	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	-1.54	CHEMBL4516	Homo sapiens	Inhibition	%	-1.54
	8097627	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.71	CHEMBL4516	Homo sapiens	Inhibition	%	0.71
	8097777	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	48.24	CHEMBL4516	Homo sapiens	Inhibition	%	48.24
	8098134	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.5	CHEMBL4516	Homo sapiens	Inhibition	%	1.5
	8098254	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-5.2	CHEMBL4516	Homo sapiens	Inhibition	%	-5.2
	8098478	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.17	CHEMBL4516	Homo sapiens	Inhibition	%	-1.17
	8098658	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-3.21	CHEMBL4516	Homo sapiens	Inhibition	%	-3.21
	8098843	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	19.96	CHEMBL4516	Homo sapiens	Inhibition	%	19.96
	8099211	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.57	CHEMBL4516	Homo sapiens	Inhibition	%	0.57
	8099353	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-2.12	CHEMBL4516	Homo sapiens	Inhibition	%	-2.12
	8099577	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.84	CHEMBL4516	Homo sapiens	Inhibition	%	1.84
	8099771	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.87	CHEMBL4516	Homo sapiens	Inhibition	%	0.87
	8099918	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.17	CHEMBL4516	Homo sapiens	Inhibition	%	4.17
	8100288	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.37	CHEMBL4516	Homo sapiens	Inhibition	%	0.37
	8100628	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-6.56	CHEMBL4516	Homo sapiens	Inhibition	%	-6.56
	8100768	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.57	CHEMBL4516	Homo sapiens	Inhibition	%	-0.57
	8101152	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	6.38	CHEMBL4516	Homo sapiens	Inhibition	%	6.38
	8101294	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	2.53	CHEMBL4516	Homo sapiens	Inhibition	%	2.53
	8101703	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.13	CHEMBL4516	Homo sapiens	Inhibition	%	1.13
	8101956	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	6.35	CHEMBL4516	Homo sapiens	Inhibition	%	6.35
	8102111	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-0.16	CHEMBL4516	Homo sapiens	Inhibition	%	-0.16
	8102466	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.92	CHEMBL4516	Homo sapiens	Inhibition	%	1.92
	8102810	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-4.2	CHEMBL4516	Homo sapiens	Inhibition	%	-4.2
	8102988	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-2.24	CHEMBL4516	Homo sapiens	Inhibition	%	-2.24
	8103184	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	11.76	CHEMBL4516	Homo sapiens	Inhibition	%	11.76
	8103408	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	36.26	CHEMBL4516	Homo sapiens	Inhibition	%	36.26
	8103546	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.84	CHEMBL4516	Homo sapiens	Inhibition	%	1.84
	8103920	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-1.57	CHEMBL4516	Homo sapiens	Inhibition	%	-1.57
	8104105	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-2.43	CHEMBL4516	Homo sapiens	Inhibition	%	-2.43
	8104253	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.98	CHEMBL4516	Homo sapiens	Inhibition	%	5.98
	8104477	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.98	CHEMBL4516	Homo sapiens	Inhibition	%	3.98
	8104623	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	8.38	CHEMBL4516	Homo sapiens	Inhibition	%	8.38
	8104961	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-3.04	CHEMBL4516	Homo sapiens	Inhibition	%	-3.04
	8105101	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-1.47	CHEMBL4516	Homo sapiens	Inhibition	%	-1.47
	8105325	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.44	CHEMBL4516	Homo sapiens	Inhibition	%	2.44
	8105491	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	0.03	CHEMBL4516	Homo sapiens	Inhibition	%	0.03
	8105629	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	3.73	CHEMBL4516	Homo sapiens	Inhibition	%	3.73
	8105853	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	-6.08	CHEMBL4516	Homo sapiens	Inhibition	%	-6.08
	8105909	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.39	CHEMBL4516	Homo sapiens	Inhibition	%	1.39
	8106133	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.82	CHEMBL4516	Homo sapiens	Inhibition	%	0.82
	8106298	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.46	CHEMBL4516	Homo sapiens	Inhibition	%	0.46
	8106454	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	2.18	CHEMBL4516	Homo sapiens	Inhibition	%	2.18
	8106678	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	6.68	CHEMBL4516	Homo sapiens	Inhibition	%	6.68
	8106807	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.2	CHEMBL4516	Homo sapiens	Inhibition	%	0.2
	8107152	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	4.85	CHEMBL4516	Homo sapiens	Inhibition	%	4.85
	8107324	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-1.08	CHEMBL4516	Homo sapiens	Inhibition	%	-1.08
	8107749	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	7.36	CHEMBL4516	Homo sapiens	Inhibition	%	7.36
	8107884	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.87	CHEMBL4516	Homo sapiens	Inhibition	%	0.87
	8108266	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.7	CHEMBL4516	Homo sapiens	Inhibition	%	2.7
	8108441	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.92	CHEMBL4516	Homo sapiens	Inhibition	%	-0.92
	8108812	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	9.1	CHEMBL4516	Homo sapiens	Inhibition	%	9.1
	8108954	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.06	CHEMBL4516	Homo sapiens	Inhibition	%	0.06
	8109178	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.21	CHEMBL4516	Homo sapiens	Inhibition	%	-0.21
	8109292	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-2.66	CHEMBL4516	Homo sapiens	Inhibition	%	-2.66
	8109646	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.52	CHEMBL4516	Homo sapiens	Inhibition	%	-0.52
	8109817	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	5.65	CHEMBL4516	Homo sapiens	Inhibition	%	5.65
	8110173	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	-1.27	CHEMBL4516	Homo sapiens	Inhibition	%	-1.27
	8110452	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.04	CHEMBL4516	Homo sapiens	Inhibition	%	1.04
	8110618	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.03	CHEMBL4516	Homo sapiens	Inhibition	%	1.03
	8111000	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	13.4	CHEMBL4516	Homo sapiens	Inhibition	%	13.4
	8111123	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.75	CHEMBL4516	Homo sapiens	Inhibition	%	1.75
	8111347	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.04	CHEMBL4516	Homo sapiens	Inhibition	%	2.04
	8111474	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-1.54	CHEMBL4516	Homo sapiens	Inhibition	%	-1.54
	8111640	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-4.81	CHEMBL4516	Homo sapiens	Inhibition	%	-4.81
	8111864	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.66	CHEMBL4516	Homo sapiens	Inhibition	%	-0.66
	8112069	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	8.12	CHEMBL4516	Homo sapiens	Inhibition	%	8.12
	8112206	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.87	CHEMBL4516	Homo sapiens	Inhibition	%	1.87
	8112430	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-2.42	CHEMBL4516	Homo sapiens	Inhibition	%	-2.42
	8112598	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	-3.16	CHEMBL4516	Homo sapiens	Inhibition	%	-3.16
	8112770	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-1.71	CHEMBL4516	Homo sapiens	Inhibition	%	-1.71
	8112994	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-3.38	CHEMBL4516	Homo sapiens	Inhibition	%	-3.38
	8113146	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.79	CHEMBL4516	Homo sapiens	Inhibition	%	1.79
	8113506	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.63	CHEMBL4516	Homo sapiens	Inhibition	%	-0.63
	8113630	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.29	CHEMBL4516	Homo sapiens	Inhibition	%	2.29
	8113970	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.89	CHEMBL4516	Homo sapiens	Inhibition	%	-0.89
	8114146	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.26	CHEMBL4516	Homo sapiens	Inhibition	%	1.26
	8114370	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.01	CHEMBL4516	Homo sapiens	Inhibition	%	5.01
	8114502	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-3.73	CHEMBL4516	Homo sapiens	Inhibition	%	-3.73
	8114778	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.21	CHEMBL4516	Homo sapiens	Inhibition	%	0.21
	8114944	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	0.43	CHEMBL4516	Homo sapiens	Inhibition	%	0.43
	8115168	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-0.27	CHEMBL4516	Homo sapiens	Inhibition	%	-0.27
	8115333	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.04	CHEMBL4516	Homo sapiens	Inhibition	%	2.04
	8115677	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.82	CHEMBL4516	Homo sapiens	Inhibition	%	1.82
	8115810	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	23.52	CHEMBL4516	Homo sapiens	Inhibition	%	23.52
	8116193	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-2.01	CHEMBL4516	Homo sapiens	Inhibition	%	-2.01
	8116396	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	8.47	CHEMBL4516	Homo sapiens	Inhibition	%	8.47
	8116754	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.04	CHEMBL4516	Homo sapiens	Inhibition	%	2.04
	8116926	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	7.9	CHEMBL4516	Homo sapiens	Inhibition	%	7.9
	8117321	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.78	CHEMBL4516	Homo sapiens	Inhibition	%	-0.78
	8117479	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	6.63	CHEMBL4516	Homo sapiens	Inhibition	%	6.63
	8117833	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-1.47	CHEMBL4516	Homo sapiens	Inhibition	%	-1.47
	8117971	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-3.08	CHEMBL4516	Homo sapiens	Inhibition	%	-3.08
	8118195	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-2.58	CHEMBL4516	Homo sapiens	Inhibition	%	-2.58
	8118311	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.11	CHEMBL4516	Homo sapiens	Inhibition	%	5.11
	8118707	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.46	CHEMBL4516	Homo sapiens	Inhibition	%	3.46
	8118843	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-2.22	CHEMBL4516	Homo sapiens	Inhibition	%	-2.22
	8119114	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.22	CHEMBL4516	Homo sapiens	Inhibition	%	-0.22
	8119497	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	0.09	CHEMBL4516	Homo sapiens	Inhibition	%	0.09
	8119664	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	4.47	CHEMBL4516	Homo sapiens	Inhibition	%	4.47
	8120007	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.22	CHEMBL4516	Homo sapiens	Inhibition	%	3.22
	8120146	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-5.75	CHEMBL4516	Homo sapiens	Inhibition	%	-5.75
	8120370	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-1.13	CHEMBL4516	Homo sapiens	Inhibition	%	-1.13
	8120530	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.53	CHEMBL4516	Homo sapiens	Inhibition	%	0.53
	8120731	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	33.76	CHEMBL4516	Homo sapiens	Inhibition	%	33.76
	8121083	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-2.97	CHEMBL4516	Homo sapiens	Inhibition	%	-2.97
	8121255	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-1.95	CHEMBL4516	Homo sapiens	Inhibition	%	-1.95
	8121479	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.21	CHEMBL4516	Homo sapiens	Inhibition	%	0.21
	8121646	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.69	CHEMBL4516	Homo sapiens	Inhibition	%	-0.69
	8121809	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.73	CHEMBL4516	Homo sapiens	Inhibition	%	1.73
	8122033	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.94	CHEMBL4516	Homo sapiens	Inhibition	%	4.94
	8122154	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.43	CHEMBL4516	Homo sapiens	Inhibition	%	0.43
	8122516	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	-1.47	CHEMBL4516	Homo sapiens	Inhibition	%	-1.47
	8122636	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.98	CHEMBL4516	Homo sapiens	Inhibition	%	4.98
	8122860	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.81	CHEMBL4516	Homo sapiens	Inhibition	%	5.81
	8123027	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.27	CHEMBL4516	Homo sapiens	Inhibition	%	5.27
	8123169	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-5.9	CHEMBL4516	Homo sapiens	Inhibition	%	-5.9
	8123393	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-3.27	CHEMBL4516	Homo sapiens	Inhibition	%	-3.27
	8123447	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.53	CHEMBL4516	Homo sapiens	Inhibition	%	2.53
	8123671	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.02	CHEMBL4516	Homo sapiens	Inhibition	%	0.02
	8123821	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.38	CHEMBL4516	Homo sapiens	Inhibition	%	3.38
	8123988	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	1.59	CHEMBL4516	Homo sapiens	Inhibition	%	1.59
	8124212	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	3.69	CHEMBL4516	Homo sapiens	Inhibition	%	3.69
	8124331	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	0.93	CHEMBL4516	Homo sapiens	Inhibition	%	0.93
	8124694	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-1.78	CHEMBL4516	Homo sapiens	Inhibition	%	-1.78
	8124859	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-6.83	CHEMBL4516	Homo sapiens	Inhibition	%	-6.83
	8125060	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	10.04	CHEMBL4516	Homo sapiens	Inhibition	%	10.04
	8125284	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	11.97	CHEMBL4516	Homo sapiens	Inhibition	%	11.97
	8125414	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.61	CHEMBL4516	Homo sapiens	Inhibition	%	2.61
	8125806	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-2.84	CHEMBL4516	Homo sapiens	Inhibition	%	-2.84
	8125970	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.78	CHEMBL4516	Homo sapiens	Inhibition	%	-1.78
	8126358	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.38	CHEMBL4516	Homo sapiens	Inhibition	%	2.38
	8126473	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.62	CHEMBL4516	Homo sapiens	Inhibition	%	0.62
	8126833	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	10.53	CHEMBL4516	Homo sapiens	Inhibition	%	10.53
	8127179	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	7.37	CHEMBL4516	Homo sapiens	Inhibition	%	7.37
	8127346	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.37	CHEMBL4516	Homo sapiens	Inhibition	%	4.37
	8127712	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	-3.03	CHEMBL4516	Homo sapiens	Inhibition	%	-3.03
	8128000	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	-0.11	CHEMBL4516	Homo sapiens	Inhibition	%	-0.11
	8128152	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.02	CHEMBL4516	Homo sapiens	Inhibition	%	0.02
	8128543	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.52	CHEMBL4516	Homo sapiens	Inhibition	%	1.52
	8128662	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-0.24	CHEMBL4516	Homo sapiens	Inhibition	%	-0.24
	8128886	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.0	CHEMBL4516	Homo sapiens	Inhibition	%	0.0
	8129023	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-0.25	CHEMBL4516	Homo sapiens	Inhibition	%	-0.25
	8129194	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.43	CHEMBL4516	Homo sapiens	Inhibition	%	-0.43
	8129418	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.33	CHEMBL4516	Homo sapiens	Inhibition	%	-0.33
	8129607	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	5.17	CHEMBL4516	Homo sapiens	Inhibition	%	5.17
	8129746	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.69	CHEMBL4516	Homo sapiens	Inhibition	%	-0.69
	8129970	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.37	CHEMBL4516	Homo sapiens	Inhibition	%	1.37
	8130131	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-3.89	CHEMBL4516	Homo sapiens	Inhibition	%	-3.89
	8130303	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.74	CHEMBL4516	Homo sapiens	Inhibition	%	1.74
	8130687	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	4.32	CHEMBL4516	Homo sapiens	Inhibition	%	4.32
	8130803	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-7.33	CHEMBL4516	Homo sapiens	Inhibition	%	-7.33
	8131027	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-0.9	CHEMBL4516	Homo sapiens	Inhibition	%	-0.9
	8131166	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-0.63	CHEMBL4516	Homo sapiens	Inhibition	%	-0.63
	8131510	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.57	CHEMBL4516	Homo sapiens	Inhibition	%	3.57
	8131677	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.99	CHEMBL4516	Homo sapiens	Inhibition	%	2.99
	8132042	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	0.21	CHEMBL4516	Homo sapiens	Inhibition	%	0.21
	8132328	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.58	CHEMBL4516	Homo sapiens	Inhibition	%	0.58
	8132475	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.32	CHEMBL4516	Homo sapiens	Inhibition	%	0.32
	8132699	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.51	CHEMBL4516	Homo sapiens	Inhibition	%	1.51
	8132867	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.33	CHEMBL4516	Homo sapiens	Inhibition	%	2.33
	8133212	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.46	CHEMBL4516	Homo sapiens	Inhibition	%	2.46
	8133350	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-3.37	CHEMBL4516	Homo sapiens	Inhibition	%	-3.37
	8133746	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.07	CHEMBL4516	Homo sapiens	Inhibition	%	1.07
	8133926	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	7.71	CHEMBL4516	Homo sapiens	Inhibition	%	7.71
	8134298	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-2.67	CHEMBL4516	Homo sapiens	Inhibition	%	-2.67
	8134458	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-2.51	CHEMBL4516	Homo sapiens	Inhibition	%	-2.51
	8134642	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.44	CHEMBL4516	Homo sapiens	Inhibition	%	-2.44
	8134866	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.5	CHEMBL4516	Homo sapiens	Inhibition	%	-0.5
	8135026	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.46	CHEMBL4516	Homo sapiens	Inhibition	%	2.46
	8135365	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-6.32	CHEMBL4516	Homo sapiens	Inhibition	%	-6.32
	8135506	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-0.35	CHEMBL4516	Homo sapiens	Inhibition	%	-0.35
	8135730	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	-1.31	CHEMBL4516	Homo sapiens	Inhibition	%	-1.31
	8135851	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	5.65	CHEMBL4516	Homo sapiens	Inhibition	%	5.65
	8136019	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.64	CHEMBL4516	Homo sapiens	Inhibition	%	1.64
	8136243	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-0.23	CHEMBL4516	Homo sapiens	Inhibition	%	-0.23
	8136387	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-2.57	CHEMBL4516	Homo sapiens	Inhibition	%	-2.57
	8136677	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.78	CHEMBL4516	Homo sapiens	Inhibition	%	0.78
	8137036	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	20.13	CHEMBL4516	Homo sapiens	Inhibition	%	20.13
	8137199	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.31	CHEMBL4516	Homo sapiens	Inhibition	%	1.31
	8137543	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.09	CHEMBL4516	Homo sapiens	Inhibition	%	1.09
	8137691	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.57	CHEMBL4516	Homo sapiens	Inhibition	%	0.57
	8138081	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.26	CHEMBL4516	Homo sapiens	Inhibition	%	-1.26
	8138260	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	4.26	CHEMBL4516	Homo sapiens	Inhibition	%	4.26
	8138632	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.02	CHEMBL4516	Homo sapiens	Inhibition	%	0.02
	8138790	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-2.81	CHEMBL4516	Homo sapiens	Inhibition	%	-2.81
	8139199	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	6.44	CHEMBL4516	Homo sapiens	Inhibition	%	6.44
	8139358	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.25	CHEMBL4516	Homo sapiens	Inhibition	%	1.25
	8139696	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-1.92	CHEMBL4516	Homo sapiens	Inhibition	%	-1.92
	8140061	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	-1.3	CHEMBL4516	Homo sapiens	Inhibition	%	-1.3
	8140184	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	6.62	CHEMBL4516	Homo sapiens	Inhibition	%	6.62
	8140567	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.92	CHEMBL4516	Homo sapiens	Inhibition	%	1.92
	8140710	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	9.23	CHEMBL4516	Homo sapiens	Inhibition	%	9.23
	8140934	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	-4.06	CHEMBL4516	Homo sapiens	Inhibition	%	-4.06
	8141012	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.0	CHEMBL4516	Homo sapiens	Inhibition	%	1.0
	8141366	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.04	CHEMBL4516	Homo sapiens	Inhibition	%	-0.04
	8141526	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	5.18	CHEMBL4516	Homo sapiens	Inhibition	%	5.18
	8141750	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.56	CHEMBL4516	Homo sapiens	Inhibition	%	1.56
	8141869	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	4.17	CHEMBL4516	Homo sapiens	Inhibition	%	4.17
	8142030	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.27	CHEMBL4516	Homo sapiens	Inhibition	%	-0.27
	8142254	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-2.49	CHEMBL4516	Homo sapiens	Inhibition	%	-2.49
	8142422	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.6	CHEMBL4516	Homo sapiens	Inhibition	%	0.6
	8142598	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.95	CHEMBL4516	Homo sapiens	Inhibition	%	2.95
	8142822	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	4.4	CHEMBL4516	Homo sapiens	Inhibition	%	4.4
	8142971	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.08	CHEMBL4516	Homo sapiens	Inhibition	%	-2.08
	8143126	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-1.73	CHEMBL4516	Homo sapiens	Inhibition	%	-1.73
	8143350	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.19	CHEMBL4516	Homo sapiens	Inhibition	%	0.19
	8143537	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.97	CHEMBL4516	Homo sapiens	Inhibition	%	3.97
	8143696	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.06	CHEMBL4516	Homo sapiens	Inhibition	%	1.06
	8143920	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	5.98	CHEMBL4516	Homo sapiens	Inhibition	%	5.98
	8144034	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-6.6	CHEMBL4516	Homo sapiens	Inhibition	%	-6.6
	8144397	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-2.99	CHEMBL4516	Homo sapiens	Inhibition	%	-2.99
	8144527	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	6.33	CHEMBL4516	Homo sapiens	Inhibition	%	6.33
	8144751	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.74	CHEMBL4516	Homo sapiens	Inhibition	%	5.74
	8144904	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.6	CHEMBL4516	Homo sapiens	Inhibition	%	0.6
	8145265	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.31	CHEMBL4516	Homo sapiens	Inhibition	%	0.31
	8145354	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-1.14	CHEMBL4516	Homo sapiens	Inhibition	%	-1.14
	8145578	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.96	CHEMBL4516	Homo sapiens	Inhibition	%	0.96
	8145702	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.15	CHEMBL4516	Homo sapiens	Inhibition	%	-0.15
	8146087	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.97	CHEMBL4516	Homo sapiens	Inhibition	%	2.97
	8146207	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.78	CHEMBL4516	Homo sapiens	Inhibition	%	0.78
	8146591	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-2.47	CHEMBL4516	Homo sapiens	Inhibition	%	-2.47
	8146758	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	5.18	CHEMBL4516	Homo sapiens	Inhibition	%	5.18
	8147151	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	19.53	CHEMBL4516	Homo sapiens	Inhibition	%	19.53
	8147293	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-4.69	CHEMBL4516	Homo sapiens	Inhibition	%	-4.69
	8147670	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-3.04	CHEMBL4516	Homo sapiens	Inhibition	%	-3.04
	8147857	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.51	CHEMBL4516	Homo sapiens	Inhibition	%	5.51
	8148239	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	1.05	CHEMBL4516	Homo sapiens	Inhibition	%	1.05
	8148353	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-3.23	CHEMBL4516	Homo sapiens	Inhibition	%	-3.23
	8148577	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-4.24	CHEMBL4516	Homo sapiens	Inhibition	%	-4.24
	8148716	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.46	CHEMBL4516	Homo sapiens	Inhibition	%	1.46
	8149078	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.95	CHEMBL4516	Homo sapiens	Inhibition	%	5.95
	8149237	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.15	CHEMBL4516	Homo sapiens	Inhibition	%	-0.15
	8149595	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	14.64	CHEMBL4516	Homo sapiens	Inhibition	%	14.64
	8149917	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.01	CHEMBL4516	Homo sapiens	Inhibition	%	1.01
	8150042	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.11	CHEMBL4516	Homo sapiens	Inhibition	%	-0.11
	8150426	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.5	CHEMBL4516	Homo sapiens	Inhibition	%	-0.5
	8150546	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.4	CHEMBL4516	Homo sapiens	Inhibition	%	0.4
	8150770	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.21	CHEMBL4516	Homo sapiens	Inhibition	%	-0.21
	8150935	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.12	CHEMBL4516	Homo sapiens	Inhibition	%	-0.12
	8151098	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.33	CHEMBL4516	Homo sapiens	Inhibition	%	1.33
	8151322	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.57	CHEMBL4516	Homo sapiens	Inhibition	%	0.57
	8151499	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.74	CHEMBL4516	Homo sapiens	Inhibition	%	3.74
	8151637	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.12	CHEMBL4516	Homo sapiens	Inhibition	%	-0.12
	8151861	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-4.67	CHEMBL4516	Homo sapiens	Inhibition	%	-4.67
	8152015	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.22	CHEMBL4516	Homo sapiens	Inhibition	%	1.22
	8152203	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.34	CHEMBL4516	Homo sapiens	Inhibition	%	5.34
	8152427	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	4.22	CHEMBL4516	Homo sapiens	Inhibition	%	4.22
	8152585	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.6	CHEMBL4516	Homo sapiens	Inhibition	%	2.6
	8152923	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-2.48	CHEMBL4516	Homo sapiens	Inhibition	%	-2.48
	8153062	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-1.39	CHEMBL4516	Homo sapiens	Inhibition	%	-1.39
	8153423	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.33	CHEMBL4516	Homo sapiens	Inhibition	%	5.33
	8153580	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.53	CHEMBL4516	Homo sapiens	Inhibition	%	-1.53
	8153804	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.32	CHEMBL4516	Homo sapiens	Inhibition	%	-0.32
	8153937	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	69.94	CHEMBL4516	Homo sapiens	Inhibition	%	69.94
	8154258	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.63	CHEMBL4516	Homo sapiens	Inhibition	%	1.63
	8154384	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.59	CHEMBL4516	Homo sapiens	Inhibition	%	-0.59
	8154608	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.81	CHEMBL4516	Homo sapiens	Inhibition	%	0.81
	8154767	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.42	CHEMBL4516	Homo sapiens	Inhibition	%	1.42
	8155111	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.83	CHEMBL4516	Homo sapiens	Inhibition	%	0.83
	8155287	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-3.46	CHEMBL4516	Homo sapiens	Inhibition	%	-3.46
	8155672	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	6.36	CHEMBL4516	Homo sapiens	Inhibition	%	6.36
	8155850	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.27	CHEMBL4516	Homo sapiens	Inhibition	%	2.27
	8156212	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-1.89	CHEMBL4516	Homo sapiens	Inhibition	%	-1.89
	8156424	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	-0.24	CHEMBL4516	Homo sapiens	Inhibition	%	-0.24
	8156798	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	-0.04	CHEMBL4516	Homo sapiens	Inhibition	%	-0.04
	8156941	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	-1.21	CHEMBL4516	Homo sapiens	Inhibition	%	-1.21
	8157285	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	17.09	CHEMBL4516	Homo sapiens	Inhibition	%	17.09
	8157426	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	-0.66	CHEMBL4516	Homo sapiens	Inhibition	%	-0.66
	8157650	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.12	CHEMBL4516	Homo sapiens	Inhibition	%	4.12
	8157780	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.35	CHEMBL4516	Homo sapiens	Inhibition	%	1.35
	8158165	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.76	CHEMBL4516	Homo sapiens	Inhibition	%	1.76
	8158415	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	14.53	CHEMBL4516	Homo sapiens	Inhibition	%	14.53
	8158573	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-0.76	CHEMBL4516	Homo sapiens	Inhibition	%	-0.76
	8158966	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-3.13	CHEMBL4516	Homo sapiens	Inhibition	%	-3.13
	8159101	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-0.44	CHEMBL4516	Homo sapiens	Inhibition	%	-0.44
	8159325	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.92	CHEMBL4516	Homo sapiens	Inhibition	%	0.92
	8159445	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.61	CHEMBL4516	Homo sapiens	Inhibition	%	1.61
	8159800	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	1.76	CHEMBL4516	Homo sapiens	Inhibition	%	1.76
	8159941	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.39	CHEMBL4516	Homo sapiens	Inhibition	%	-0.39
	8160302	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.63	CHEMBL4516	Homo sapiens	Inhibition	%	2.63
	8160452	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.25	CHEMBL4516	Homo sapiens	Inhibition	%	-0.25
	8160746	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	0.37	CHEMBL4516	Homo sapiens	Inhibition	%	0.37
	8161120	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.59	CHEMBL4516	Homo sapiens	Inhibition	%	2.59
	8161263	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	-0.46	CHEMBL4516	Homo sapiens	Inhibition	%	-0.46
	8161487	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	0.87	CHEMBL4516	Homo sapiens	Inhibition	%	0.87
	8161612	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.28	CHEMBL4516	Homo sapiens	Inhibition	%	0.28
	8161974	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	-0.33	CHEMBL4516	Homo sapiens	Inhibition	%	-0.33
	8162104	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	17.09	CHEMBL4516	Homo sapiens	Inhibition	%	17.09
	8162488	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.74	CHEMBL4516	Homo sapiens	Inhibition	%	-0.74
	8162741	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	68.73	CHEMBL4516	Homo sapiens	Inhibition	%	68.73
	8162889	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	3.96	CHEMBL4516	Homo sapiens	Inhibition	%	3.96
	8163113	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	20.54	CHEMBL4516	Homo sapiens	Inhibition	%	20.54
	8163282	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	-0.22	CHEMBL4516	Homo sapiens	Inhibition	%	-0.22
	8163640	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	-0.42	CHEMBL4516	Homo sapiens	Inhibition	%	-0.42
	8163763	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	5.14	CHEMBL4516	Homo sapiens	Inhibition	%	5.14
	8164121	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	17.9	CHEMBL4516	Homo sapiens	Inhibition	%	17.9
	8164261	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.39	CHEMBL4516	Homo sapiens	Inhibition	%	0.39
	8164485	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.52	CHEMBL4516	Homo sapiens	Inhibition	%	-0.52
	8164640	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	0.0	CHEMBL4516	Homo sapiens	Inhibition	%	0.0
	8164784	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.81	CHEMBL4516	Homo sapiens	Inhibition	%	-0.81
	8165008	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-0.45	CHEMBL4516	Homo sapiens	Inhibition	%	-0.45
	8165078	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	-0.11	CHEMBL4516	Homo sapiens	Inhibition	%	-0.11
	8165302	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.88	CHEMBL4516	Homo sapiens	Inhibition	%	2.88
	8165443	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-0.61	CHEMBL4516	Homo sapiens	Inhibition	%	-0.61
	8165810	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-0.38	CHEMBL4516	Homo sapiens	Inhibition	%	-0.38
	8165936	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	-0.35	CHEMBL4516	Homo sapiens	Inhibition	%	-0.35
	8166298	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.84	CHEMBL4516	Homo sapiens	Inhibition	%	4.84
	8166428	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	-0.93	CHEMBL4516	Homo sapiens	Inhibition	%	-0.93
	8166652	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.63	CHEMBL4516	Homo sapiens	Inhibition	%	2.63
	8166753	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	-0.15	CHEMBL4516	Homo sapiens	Inhibition	%	-0.15
	8167065	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	6.6	CHEMBL4516	Homo sapiens	Inhibition	%	6.6
	8167430	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.48	CHEMBL4516	Homo sapiens	Inhibition	%	2.48
	8167594	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	-0.12	CHEMBL4516	Homo sapiens	Inhibition	%	-0.12
	8167951	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.28	CHEMBL4516	Homo sapiens	Inhibition	%	3.28
	8168075	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.04	CHEMBL4516	Homo sapiens	Inhibition	%	2.04
	8168299	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	12.4	CHEMBL4516	Homo sapiens	Inhibition	%	12.4
	8168440	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	0.04	CHEMBL4516	Homo sapiens	Inhibition	%	0.04
	8168800	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.11	CHEMBL4516	Homo sapiens	Inhibition	%	0.11
	8168964	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	2.93	CHEMBL4516	Homo sapiens	Inhibition	%	2.93
	8169330	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-1.86	CHEMBL4516	Homo sapiens	Inhibition	%	-1.86
	8169634	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	-0.15	CHEMBL4516	Homo sapiens	Inhibition	%	-0.15
	8169768	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.91	CHEMBL4516	Homo sapiens	Inhibition	%	1.91
	8170137	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-1.97	CHEMBL4516	Homo sapiens	Inhibition	%	-1.97
	8170262	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	-1.02	CHEMBL4516	Homo sapiens	Inhibition	%	-1.02
	8170486	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	-1.52	CHEMBL4516	Homo sapiens	Inhibition	%	-1.52
	8170626	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	3.52	CHEMBL4516	Homo sapiens	Inhibition	%	3.52
	8170985	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-1.68	CHEMBL4516	Homo sapiens	Inhibition	%	-1.68
	8171182	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.61	CHEMBL4516	Homo sapiens	Inhibition	%	1.61
	8171399	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	42.33	CHEMBL4516	Homo sapiens	Inhibition	%	42.33
	8171764	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	6.74	CHEMBL4516	Homo sapiens	Inhibition	%	6.74
	8171917	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.1	CHEMBL4516	Homo sapiens	Inhibition	%	0.1
	8172141	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.68	CHEMBL4516	Homo sapiens	Inhibition	%	-0.68
	8172273	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	-0.3	CHEMBL4516	Homo sapiens	Inhibition	%	-0.3
	8172625	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.22	CHEMBL4516	Homo sapiens	Inhibition	%	-0.22
	8172767	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.55	CHEMBL4516	Homo sapiens	Inhibition	%	2.55
	8173127	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.38	CHEMBL4516	Homo sapiens	Inhibition	%	-0.38
	8173292	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	-0.11	CHEMBL4516	Homo sapiens	Inhibition	%	-0.11
	8173516	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.78	CHEMBL4516	Homo sapiens	Inhibition	%	3.78
	8173657	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	0.24	CHEMBL4516	Homo sapiens	Inhibition	%	0.24
	8173968	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	2.43	CHEMBL4516	Homo sapiens	Inhibition	%	2.43
	8174100	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	-0.75	CHEMBL4516	Homo sapiens	Inhibition	%	-0.75
	8174324	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.85	CHEMBL4516	Homo sapiens	Inhibition	%	4.85
	8174472	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.69	CHEMBL4516	Homo sapiens	Inhibition	%	0.69
	8174818	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.37	CHEMBL4516	Homo sapiens	Inhibition	%	0.37
	8174961	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	33.25	CHEMBL4516	Homo sapiens	Inhibition	%	33.25
	8175321	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-0.92	CHEMBL4516	Homo sapiens	Inhibition	%	-0.92
	8175577	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.59	CHEMBL4516	Homo sapiens	Inhibition	%	3.59
	8175740	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	-1.1	CHEMBL4516	Homo sapiens	Inhibition	%	-1.1
	8175964	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.42	CHEMBL4516	Homo sapiens	Inhibition	%	2.42
	8176117	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	43.39	CHEMBL4516	Homo sapiens	Inhibition	%	43.39
	8176490	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.22	CHEMBL4516	Homo sapiens	Inhibition	%	0.22
	8176622	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	1.93	CHEMBL4516	Homo sapiens	Inhibition	%	1.93
	8176976	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.54	CHEMBL4516	Homo sapiens	Inhibition	%	-0.54
	8177118	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-0.28	CHEMBL4516	Homo sapiens	Inhibition	%	-0.28
	8177342	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-0.43	CHEMBL4516	Homo sapiens	Inhibition	%	-0.43
	8177480	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	0.84	CHEMBL4516	Homo sapiens	Inhibition	%	0.84
	8177868	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	-0.11	CHEMBL4516	Homo sapiens	Inhibition	%	-0.11
	8178008	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-0.62	CHEMBL4516	Homo sapiens	Inhibition	%	-0.62
	8178320	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	-0.3	CHEMBL4516	Homo sapiens	Inhibition	%	-0.3
	8178671	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	-0.63	CHEMBL4516	Homo sapiens	Inhibition	%	-0.63
	8178820	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-1.55	CHEMBL4516	Homo sapiens	Inhibition	%	-1.55
	8179167	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	-0.19	CHEMBL4516	Homo sapiens	Inhibition	%	-0.19
	8179311	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	0.07	CHEMBL4516	Homo sapiens	Inhibition	%	0.07
	8179535	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.72	CHEMBL4516	Homo sapiens	Inhibition	%	3.72
	8179672	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-1.08	CHEMBL4516	Homo sapiens	Inhibition	%	-1.08
	8179929	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	0.2	CHEMBL4516	Homo sapiens	Inhibition	%	0.2
	8180307	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.43	CHEMBL4516	Homo sapiens	Inhibition	%	-0.43
	8180463	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	90.64	CHEMBL4516	Homo sapiens	Inhibition	%	90.64
	8180835	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	4.01	CHEMBL4516	Homo sapiens	Inhibition	%	4.01
	8180968	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	-0.59	CHEMBL4516	Homo sapiens	Inhibition	%	-0.59
	8181192	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	3.17	CHEMBL4516	Homo sapiens	Inhibition	%	3.17
	8181323	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.23	CHEMBL4516	Homo sapiens	Inhibition	%	-0.23
	8181687	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	0.05	CHEMBL4516	Homo sapiens	Inhibition	%	0.05
	8181826	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	11.76	CHEMBL4516	Homo sapiens	Inhibition	%	11.76
	8182050	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	0.67	CHEMBL4516	Homo sapiens	Inhibition	%	0.67
	8182213	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.87	CHEMBL4516	Homo sapiens	Inhibition	%	3.87
	8182353	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-0.28	CHEMBL4516	Homo sapiens	Inhibition	%	-0.28
	8182577	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-1.12	CHEMBL4516	Homo sapiens	Inhibition	%	-1.12
	8182669	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	-0.73	CHEMBL4516	Homo sapiens	Inhibition	%	-0.73
	8183015	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.53	CHEMBL4516	Homo sapiens	Inhibition	%	1.53
	8183164	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-0.07	CHEMBL4516	Homo sapiens	Inhibition	%	-0.07
	8183388	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-0.94	CHEMBL4516	Homo sapiens	Inhibition	%	-0.94
	8183517	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	7.63	CHEMBL4516	Homo sapiens	Inhibition	%	7.63
	8183883	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-0.18	CHEMBL4516	Homo sapiens	Inhibition	%	-0.18
	8184019	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.54	CHEMBL4516	Homo sapiens	Inhibition	%	0.54
	8184243	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.29	CHEMBL4516	Homo sapiens	Inhibition	%	-0.29
	8184285	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.63	CHEMBL4516	Homo sapiens	Inhibition	%	2.63
	8184509	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.36	CHEMBL4516	Homo sapiens	Inhibition	%	-0.36
	8184656	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.14	CHEMBL4516	Homo sapiens	Inhibition	%	-1.14
	8184813	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.99	CHEMBL4516	Homo sapiens	Inhibition	%	1.99
	8185037	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	20.36	CHEMBL4516	Homo sapiens	Inhibition	%	20.36
	8185186	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.23	CHEMBL4516	Homo sapiens	Inhibition	%	0.23
	8185541	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-0.05	CHEMBL4516	Homo sapiens	Inhibition	%	-0.05
	8185672	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.16	CHEMBL4516	Homo sapiens	Inhibition	%	0.16
	8185896	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	-0.66	CHEMBL4516	Homo sapiens	Inhibition	%	-0.66
	8186035	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	-1.04	CHEMBL4516	Homo sapiens	Inhibition	%	-1.04
	8186400	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.1	CHEMBL4516	Homo sapiens	Inhibition	%	4.1
	8186564	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	-0.56	CHEMBL4516	Homo sapiens	Inhibition	%	-0.56
	8186927	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	-0.24	CHEMBL4516	Homo sapiens	Inhibition	%	-0.24
	8187025	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.25	CHEMBL4516	Homo sapiens	Inhibition	%	0.25
	8187249	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.43	CHEMBL4516	Homo sapiens	Inhibition	%	0.43
	8187373	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	-0.42	CHEMBL4516	Homo sapiens	Inhibition	%	-0.42
	8187745	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.02	CHEMBL4516	Homo sapiens	Inhibition	%	0.02
	8187874	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.17	CHEMBL4516	Homo sapiens	Inhibition	%	5.17
	8188098	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.98	CHEMBL4516	Homo sapiens	Inhibition	%	2.98
	8188241	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.52	CHEMBL4516	Homo sapiens	Inhibition	%	2.52
	8188600	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.45	CHEMBL4516	Homo sapiens	Inhibition	%	-0.45
	8188874	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.0	CHEMBL4516	Homo sapiens	Inhibition	%	2.0
	8189022	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.0	CHEMBL4516	Homo sapiens	Inhibition	%	0.0
	8189402	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	0.02	CHEMBL4516	Homo sapiens	Inhibition	%	0.02
	8189551	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.33	CHEMBL4516	Homo sapiens	Inhibition	%	-0.33
	8189775	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.27	CHEMBL4516	Homo sapiens	Inhibition	%	-0.27
	8189907	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	7.35	CHEMBL4516	Homo sapiens	Inhibition	%	7.35
	8190263	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	-2.56	CHEMBL4516	Homo sapiens	Inhibition	%	-2.56
	8190403	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	0.84	CHEMBL4516	Homo sapiens	Inhibition	%	0.84
	8190764	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	0.14	CHEMBL4516	Homo sapiens	Inhibition	%	0.14
	8190928	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	-0.21	CHEMBL4516	Homo sapiens	Inhibition	%	-0.21
	8191152	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	-0.25	CHEMBL4516	Homo sapiens	Inhibition	%	-0.25
	8191290	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	-0.69	CHEMBL4516	Homo sapiens	Inhibition	%	-0.69
	8191610	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-0.15	CHEMBL4516	Homo sapiens	Inhibition	%	-0.15
	8191732	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.27	CHEMBL4516	Homo sapiens	Inhibition	%	2.27
	8191956	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	-0.57	CHEMBL4516	Homo sapiens	Inhibition	%	-0.57
	8192105	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.07	CHEMBL4516	Homo sapiens	Inhibition	%	0.07
	8192458	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	6.58	CHEMBL4516	Homo sapiens	Inhibition	%	6.58
	8192602	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	-0.01	CHEMBL4516	Homo sapiens	Inhibition	%	-0.01
	8192962	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.76	CHEMBL4516	Homo sapiens	Inhibition	%	-0.76
	8193234	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-1.04	CHEMBL4516	Homo sapiens	Inhibition	%	-1.04
	8193379	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.03	CHEMBL4516	Homo sapiens	Inhibition	%	0.03
	8193603	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-0.28	CHEMBL4516	Homo sapiens	Inhibition	%	-0.28
	8193760	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	0.03	CHEMBL4516	Homo sapiens	Inhibition	%	0.03
	8194133	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	5.42	CHEMBL4516	Homo sapiens	Inhibition	%	5.42
	8194264	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	0.29	CHEMBL4516	Homo sapiens	Inhibition	%	0.29
	8194619	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.19	CHEMBL4516	Homo sapiens	Inhibition	%	0.19
	8194762	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-0.04	CHEMBL4516	Homo sapiens	Inhibition	%	-0.04
	8194986	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	-0.16	CHEMBL4516	Homo sapiens	Inhibition	%	-0.16
	8195119	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.92	CHEMBL4516	Homo sapiens	Inhibition	%	2.92
	8195507	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.33	CHEMBL4516	Homo sapiens	Inhibition	%	1.33
	8195646	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	0.27	CHEMBL4516	Homo sapiens	Inhibition	%	0.27
	8195968	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.82	CHEMBL4516	Homo sapiens	Inhibition	%	0.82
	8196309	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	-0.25	CHEMBL4516	Homo sapiens	Inhibition	%	-0.25
	8196459	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.01	CHEMBL4516	Homo sapiens	Inhibition	%	1.01
	8196811	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.82	CHEMBL4516	Homo sapiens	Inhibition	%	2.82
	8196952	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.94	CHEMBL4516	Homo sapiens	Inhibition	%	2.94
	8197176	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-0.66	CHEMBL4516	Homo sapiens	Inhibition	%	-0.66
	8197313	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.62	CHEMBL4516	Homo sapiens	Inhibition	%	-0.62
	8197588	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-1.25	CHEMBL4516	Homo sapiens	Inhibition	%	-1.25
	8197952	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.18	CHEMBL4516	Homo sapiens	Inhibition	%	2.18
	8198109	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.18	CHEMBL4516	Homo sapiens	Inhibition	%	0.18
	8198471	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-0.62	CHEMBL4516	Homo sapiens	Inhibition	%	-0.62
	8198601	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	0.79	CHEMBL4516	Homo sapiens	Inhibition	%	0.79
	8198825	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	-0.01	CHEMBL4516	Homo sapiens	Inhibition	%	-0.01
	8198956	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.98	CHEMBL4516	Homo sapiens	Inhibition	%	0.98
	8199328	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	1.32	CHEMBL4516	Homo sapiens	Inhibition	%	1.32
	8199462	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	-0.09	CHEMBL4516	Homo sapiens	Inhibition	%	-0.09
	8199849	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.35	CHEMBL4516	Homo sapiens	Inhibition	%	0.35
	8199987	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	-0.19	CHEMBL4516	Homo sapiens	Inhibition	%	-0.19
	8200211	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	0.02	CHEMBL4516	Homo sapiens	Inhibition	%	0.02
	8200315	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.06	CHEMBL4516	Homo sapiens	Inhibition	%	-0.06
	8200654	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	0.11	CHEMBL4516	Homo sapiens	Inhibition	%	0.11
	8200804	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	7.71	CHEMBL4516	Homo sapiens	Inhibition	%	7.71
	8201028	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	0.21	CHEMBL4516	Homo sapiens	Inhibition	%	0.21
	8201158	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	7.52	CHEMBL4516	Homo sapiens	Inhibition	%	7.52
	8201517	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-1.1	CHEMBL4516	Homo sapiens	Inhibition	%	-1.1
	8201650	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.8	CHEMBL4516	Homo sapiens	Inhibition	%	-1.8
	8201874	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	1.91	CHEMBL4516	Homo sapiens	Inhibition	%	1.91
	8201929	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-0.31	CHEMBL4516	Homo sapiens	Inhibition	%	-0.31
	8202293	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.3	CHEMBL4516	Homo sapiens	Inhibition	%	-0.3
	8202460	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.85	CHEMBL4516	Homo sapiens	Inhibition	%	2.85
	8202684	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.89	CHEMBL4516	Homo sapiens	Inhibition	%	1.89
	8202809	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.14	CHEMBL4516	Homo sapiens	Inhibition	%	2.14
	8203163	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	0.95	CHEMBL4516	Homo sapiens	Inhibition	%	0.95
	8203294	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-0.27	CHEMBL4516	Homo sapiens	Inhibition	%	-0.27
	8203664	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-0.89	CHEMBL4516	Homo sapiens	Inhibition	%	-0.89
	8203798	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.32	CHEMBL4516	Homo sapiens	Inhibition	%	2.32
	8204022	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	-0.6	CHEMBL4516	Homo sapiens	Inhibition	%	-0.6
	8204188	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.93	CHEMBL4516	Homo sapiens	Inhibition	%	1.93
	8204549	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	-2.04	CHEMBL4516	Homo sapiens	Inhibition	%	-2.04
	8204654	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.52	CHEMBL4516	Homo sapiens	Inhibition	%	0.52
	8204878	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.09	CHEMBL4516	Homo sapiens	Inhibition	%	-0.09
	8204993	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.49	CHEMBL4516	Homo sapiens	Inhibition	%	2.49
	8205366	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	-0.69	CHEMBL4516	Homo sapiens	Inhibition	%	-0.69
	8205502	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.25	CHEMBL4516	Homo sapiens	Inhibition	%	2.25
	8205865	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	-0.72	CHEMBL4516	Homo sapiens	Inhibition	%	-0.72
	8206221	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.0	CHEMBL4516	Homo sapiens	Inhibition	%	-1.0
	8206273	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.73	CHEMBL4516	Homo sapiens	Inhibition	%	1.73
	8206497	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.16	CHEMBL4516	Homo sapiens	Inhibition	%	0.16
	8206640	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.5	CHEMBL4516	Homo sapiens	Inhibition	%	-1.5
	8207044	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	16.35	CHEMBL4516	Homo sapiens	Inhibition	%	16.35
	8207170	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	-0.36	CHEMBL4516	Homo sapiens	Inhibition	%	-0.36
	8207524	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	1.56	CHEMBL4516	Homo sapiens	Inhibition	%	1.56
	8207656	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	0.18	CHEMBL4516	Homo sapiens	Inhibition	%	0.18
	8207880	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	0.79	CHEMBL4516	Homo sapiens	Inhibition	%	0.79
	8208025	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-2.56	CHEMBL4516	Homo sapiens	Inhibition	%	-2.56
	8208381	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.02	CHEMBL4516	Homo sapiens	Inhibition	%	3.02
	8208547	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.1	CHEMBL4516	Homo sapiens	Inhibition	%	3.1
	8208904	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.84	CHEMBL4516	Homo sapiens	Inhibition	%	4.84
	8209233	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.52	CHEMBL4516	Homo sapiens	Inhibition	%	-0.52
	8209349	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.29	CHEMBL4516	Homo sapiens	Inhibition	%	0.29
	8209573	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-0.21	CHEMBL4516	Homo sapiens	Inhibition	%	-0.21
	8209723	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-0.42	CHEMBL4516	Homo sapiens	Inhibition	%	-0.42
	8209859	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	5.56	CHEMBL4516	Homo sapiens	Inhibition	%	5.56
	8210083	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	1.89	CHEMBL4516	Homo sapiens	Inhibition	%	1.89
	8210224	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.73	CHEMBL4516	Homo sapiens	Inhibition	%	2.73
	8210584	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.59	CHEMBL4516	Homo sapiens	Inhibition	%	-0.59
	8210843	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.24	CHEMBL4516	Homo sapiens	Inhibition	%	1.24
	8210987	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	-0.56	CHEMBL4516	Homo sapiens	Inhibition	%	-0.56
	8211211	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	-2.93	CHEMBL4516	Homo sapiens	Inhibition	%	-2.93
	8211381	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-0.29	CHEMBL4516	Homo sapiens	Inhibition	%	-0.29
	8211504	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.58	CHEMBL4516	Homo sapiens	Inhibition	%	5.58
	8211728	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-0.84	CHEMBL4516	Homo sapiens	Inhibition	%	-0.84
	8211857	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	13.49	CHEMBL4516	Homo sapiens	Inhibition	%	13.49
	8212213	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	-0.95	CHEMBL4516	Homo sapiens	Inhibition	%	-0.95
	8212354	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	0.19	CHEMBL4516	Homo sapiens	Inhibition	%	0.19
	8212578	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	0.87	CHEMBL4516	Homo sapiens	Inhibition	%	0.87
	8212711	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	-0.4	CHEMBL4516	Homo sapiens	Inhibition	%	-0.4
	8212881	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	22.7	CHEMBL4516	Homo sapiens	Inhibition	%	22.7
	8213105	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.31	CHEMBL4516	Homo sapiens	Inhibition	%	-0.31
	8213234	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	35.73	CHEMBL4516	Homo sapiens	Inhibition	%	35.73
	8213562	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.29	CHEMBL4516	Homo sapiens	Inhibition	%	-0.29
	8213899	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	-0.58	CHEMBL4516	Homo sapiens	Inhibition	%	-0.58
	8214046	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-1.48	CHEMBL4516	Homo sapiens	Inhibition	%	-1.48
	8214407	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	5.55	CHEMBL4516	Homo sapiens	Inhibition	%	5.55
	8214541	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-0.17	CHEMBL4516	Homo sapiens	Inhibition	%	-0.17
	8214765	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	1.81	CHEMBL4516	Homo sapiens	Inhibition	%	1.81
	8214917	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	6.85	CHEMBL4516	Homo sapiens	Inhibition	%	6.85
	8215168	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.42	CHEMBL4516	Homo sapiens	Inhibition	%	0.42
	8215545	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.52	CHEMBL4516	Homo sapiens	Inhibition	%	0.52
	8215709	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-1.5	CHEMBL4516	Homo sapiens	Inhibition	%	-1.5
	8216052	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.26	CHEMBL4516	Homo sapiens	Inhibition	%	3.26
	8216171	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-0.03	CHEMBL4516	Homo sapiens	Inhibition	%	-0.03
	8216395	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.97	CHEMBL4516	Homo sapiens	Inhibition	%	1.97
	8216531	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	0.14	CHEMBL4516	Homo sapiens	Inhibition	%	0.14
	8216893	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.86	CHEMBL4516	Homo sapiens	Inhibition	%	5.86
	8217027	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.11	CHEMBL4516	Homo sapiens	Inhibition	%	2.11
	8217425	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.06	CHEMBL4516	Homo sapiens	Inhibition	%	1.06
	8217556	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	1.12	CHEMBL4516	Homo sapiens	Inhibition	%	1.12
	8217881	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.46	CHEMBL4516	Homo sapiens	Inhibition	%	-0.46
	8218220	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.77	CHEMBL4516	Homo sapiens	Inhibition	%	0.77
	8218347	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	2.1	CHEMBL4516	Homo sapiens	Inhibition	%	2.1
	8218571	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	7.78	CHEMBL4516	Homo sapiens	Inhibition	%	7.78
	8218714	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	0.52	CHEMBL4516	Homo sapiens	Inhibition	%	0.52
	8219069	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	-0.69	CHEMBL4516	Homo sapiens	Inhibition	%	-0.69
	8219229	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-2.76	CHEMBL4516	Homo sapiens	Inhibition	%	-2.76
	8219479	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.54	CHEMBL4516	Homo sapiens	Inhibition	%	1.54
	8219864	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	-0.11	CHEMBL4516	Homo sapiens	Inhibition	%	-0.11
	8220033	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	-0.06	CHEMBL4516	Homo sapiens	Inhibition	%	-0.06
	8220386	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	-0.12	CHEMBL4516	Homo sapiens	Inhibition	%	-0.12
	8220724	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	17.16	CHEMBL4516	Homo sapiens	Inhibition	%	17.16
	8220862	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	0.38	CHEMBL4516	Homo sapiens	Inhibition	%	0.38
	8221222	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	39.99	CHEMBL4516	Homo sapiens	Inhibition	%	39.99
	8221355	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	-0.32	CHEMBL4516	Homo sapiens	Inhibition	%	-0.32
	8221579	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.08	CHEMBL4516	Homo sapiens	Inhibition	%	1.08
	8221744	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.18	CHEMBL4516	Homo sapiens	Inhibition	%	0.18
	8221875	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	5.41	CHEMBL4516	Homo sapiens	Inhibition	%	5.41
	8222099	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	0.06	CHEMBL4516	Homo sapiens	Inhibition	%	0.06
	8222197	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	-0.63	CHEMBL4516	Homo sapiens	Inhibition	%	-0.63
	8222421	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.28	CHEMBL4516	Homo sapiens	Inhibition	%	3.28
	8222555	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	-0.91	CHEMBL4516	Homo sapiens	Inhibition	%	-0.91
	8222897	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.9	CHEMBL4516	Homo sapiens	Inhibition	%	1.9
	8223041	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	6.52	CHEMBL4516	Homo sapiens	Inhibition	%	6.52
	8223394	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.0	CHEMBL4516	Homo sapiens	Inhibition	%	1.0
	8223555	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.99	CHEMBL4516	Homo sapiens	Inhibition	%	1.99
	8223779	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.63	CHEMBL4516	Homo sapiens	Inhibition	%	-0.63
	8223805	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	0.29	CHEMBL4516	Homo sapiens	Inhibition	%	0.29
	8224029	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.6	CHEMBL4516	Homo sapiens	Inhibition	%	1.6
	8224191	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.01	CHEMBL4516	Homo sapiens	Inhibition	%	1.01
	8224361	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	-0.62	CHEMBL4516	Homo sapiens	Inhibition	%	-0.62
	8224585	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-0.78	CHEMBL4516	Homo sapiens	Inhibition	%	-0.78
	8224720	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.68	CHEMBL4516	Homo sapiens	Inhibition	%	2.68
	8225058	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	64.57	CHEMBL4516	Homo sapiens	Inhibition	%	64.57
	8225192	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	0.59	CHEMBL4516	Homo sapiens	Inhibition	%	0.59
	8225416	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	0.11	CHEMBL4516	Homo sapiens	Inhibition	%	0.11
	8225554	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.51	CHEMBL4516	Homo sapiens	Inhibition	%	1.51
	8225913	CHEMBL1961884	GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	0.22	CHEMBL4516	Homo sapiens	Inhibition	%	0.22
	8226071	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	5.06	CHEMBL4516	Homo sapiens	Inhibition	%	5.06
	8226420	CHEMBL1961885	GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	-0.95	CHEMBL4516	Homo sapiens	Inhibition	%	-0.95
inactive	9506755	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506756	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506757	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506758	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506759	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9506760	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506761	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
active	9506762	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	1258.93	CHEMBL4516	Homo sapiens	pKi		5.9
inactive	9506763	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506764	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506765	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506766	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9506767	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506768	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506769	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506770	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	630.96	CHEMBL4516	Homo sapiens	pKi		6.2
active	9506771	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	3162.28	CHEMBL4516	Homo sapiens	pKi		5.5
active	9506772	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	=	Ki	nM	1258.93	CHEMBL4516	Homo sapiens	pKi		5.9
active	9506773	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9506774	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506775	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506776	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506777	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2006631	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9506778	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506779	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506780	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506781	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506782	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506783	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506784	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506785	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506786	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	=	Ki	nM	794.33	CHEMBL4516	Homo sapiens	pKi		6.1
inactive	9506787	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506788	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506789	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506790	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9506791	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506792	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506793	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506794	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506795	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506796	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506797	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506798	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	39.81	CHEMBL4516	Homo sapiens	pKi		7.4
active	9506799	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9506800	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506801	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506802	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506803	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	794.33	CHEMBL4516	Homo sapiens	pKi		6.1
inactive	9506804	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506805	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9506806	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506807	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506808	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506809	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506810	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506811	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506812	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9506813	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506814	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
active	9506815	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	1995.26	CHEMBL4516	Homo sapiens	pKi		5.7
inactive	9506816	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506817	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NCc1ccc(Cl)cc1)Nc1cccc2[nH]ncc12		CHEMBL1977713	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506818	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506819	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	158.49	CHEMBL4516	Homo sapiens	pKi		6.8
inactive	9506820	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506821	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506822	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506823	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	2511.89	CHEMBL4516	Homo sapiens	pKi		5.6
inactive	9506824	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506825	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9506826	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506827	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506828	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	199.53	CHEMBL4516	Homo sapiens	pKi		6.7
inactive	9506829	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506830	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506831	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506832	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	1258.93	CHEMBL4516	Homo sapiens	pKi		5.9
inactive	9506833	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2Br)C1		CHEMBL2004647	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506834	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506835	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	=	Ki	nM	1995.26	CHEMBL4516	Homo sapiens	pKi		5.7
active	9506836	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	=	Ki	nM	199.53	CHEMBL4516	Homo sapiens	pKi		6.7
active	9506837	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
active	9506838	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9506839	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506840	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	25.12	CHEMBL4516	Homo sapiens	pKi		7.6
active	9506841	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	1584.89	CHEMBL4516	Homo sapiens	pKi		5.8
active	9506842	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	=	Ki	nM	251.19	CHEMBL4516	Homo sapiens	pKi		6.6
inactive	9506843	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506844	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	=	Ki	nM	3162.28	CHEMBL4516	Homo sapiens	pKi		5.5
inactive	9506845	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506846	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	=	Ki	nM	1000.0	CHEMBL4516	Homo sapiens	pKi		6.0
active	9506847	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
active	9506848	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	630.96	CHEMBL4516	Homo sapiens	pKi		6.2
active	9506849	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	251.19	CHEMBL4516	Homo sapiens	pKi		6.6
inactive	9506850	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506851	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9506852	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506853	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506854	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506855	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cn1ncc2c1CCCC2=O		CHEMBL1981107	<	Ki	nM	25118.86	CHEMBL4516	Homo sapiens	pKi		4.6
inactive	9506856	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506857	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506858	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	630.96	CHEMBL4516	Homo sapiens	pKi		6.2
inactive	9506859	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9506860	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506861	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506862	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506863	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506864	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506865	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9506866	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506867	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9506868	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506869	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OCCNc1cc2cc(-c3ccccc3)ccc2cn1		CHEMBL1989957	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506870	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506871	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506872	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9506873	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506874	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506875	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	1000.0	CHEMBL4516	Homo sapiens	pKi		6.0
inactive	9506876	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506877	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	=	Ki	nM	630.96	CHEMBL4516	Homo sapiens	pKi		6.2
inactive	9506878	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506879	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506880	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506881	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506882	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506883	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506884	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9506885	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506886	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506887	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506888	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	1000.0	CHEMBL4516	Homo sapiens	pKi		6.0
inactive	9506889	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506890	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
active	9506891	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	630.96	CHEMBL4516	Homo sapiens	pKi		6.2
inactive	9506892	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506893	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506894	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506895	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9506896	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506897	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	1995.26	CHEMBL4516	Homo sapiens	pKi		5.7
active	9506898	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9506899	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506900	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506901	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506902	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9506903	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506904	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	398.11	CHEMBL4516	Homo sapiens	pKi		6.4
inactive	9506905	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506906	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	1995.26	CHEMBL4516	Homo sapiens	pKi		5.7
inactive	9506907	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506908	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506909	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506910	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506911	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506912	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506913	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	316.23	CHEMBL4516	Homo sapiens	pKi		6.5
active	9506914	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	=	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506915	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506916	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506917	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506918	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	794.33	CHEMBL4516	Homo sapiens	pKi		6.1
active	9506919	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	=	Ki	nM	1995.26	CHEMBL4516	Homo sapiens	pKi		5.7
inactive	9506920	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506921	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506922	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506923	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506924	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	=	Ki	nM	2511.89	CHEMBL4516	Homo sapiens	pKi		5.6
inactive	9506925	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506926	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506927	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506928	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506929	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	=	Ki	nM	1000.0	CHEMBL4516	Homo sapiens	pKi		6.0
inactive	9506930	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506931	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506932	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506933	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506934	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
active	9506935	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	=	Ki	nM	25.12	CHEMBL4516	Homo sapiens	pKi		7.6
inactive	9506936	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506937	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9506938	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506939	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506940	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	3162.28	CHEMBL4516	Homo sapiens	pKi		5.5
inactive	9506941	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506942	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506943	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506944	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506945	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	=	Ki	nM	158.49	CHEMBL4516	Homo sapiens	pKi		6.8
active	9506946	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
active	9506947	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
active	9506948	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	501.19	CHEMBL4516	Homo sapiens	pKi		6.3
inactive	9506949	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506950	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O)S(C)(=O)=O		CHEMBL1980497	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
active	9506951	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	=	Ki	nM	1995.26	CHEMBL4516	Homo sapiens	pKi		5.7
active	9506952	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9506953	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506954	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506955	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506956	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506957	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	=	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506958	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506959	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506960	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	=	Ki	nM	125.89	CHEMBL4516	Homo sapiens	pKi		6.9
inactive	9506961	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506962	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506963	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9506964	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506965	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	19.95	CHEMBL4516	Homo sapiens	pKi		7.7
active	9506966	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	1995.26	CHEMBL4516	Homo sapiens	pKi		5.7
inactive	9506967	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506968	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506969	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506970	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9506971	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506972	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506973	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506974	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506975	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506976	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	199.53	CHEMBL4516	Homo sapiens	pKi		6.7
inactive	9506977	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506978	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	316.23	CHEMBL4516	Homo sapiens	pKi		6.5
inactive	9506979	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506980	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506981	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506982	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506983	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=O)Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2006609	=	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506984	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506985	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
active	9506986	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9506987	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506988	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506989	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506990	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506991	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506992	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506993	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506994	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9506995	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506996	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	79.43	CHEMBL4516	Homo sapiens	pKi		7.1
inactive	9506997	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9506998	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	630.96	CHEMBL4516	Homo sapiens	pKi		6.2
inactive	9510912	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510913	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9510914	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510915	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510916	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510917	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510918	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510919	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510920	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510921	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510922	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510923	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510924	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9510925	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510926	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510927	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510928	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510929	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	1995.26	CHEMBL4516	Homo sapiens	pKi		5.7
inactive	9510930	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510931	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	3162.28	CHEMBL4516	Homo sapiens	pKi		5.5
active	9510932	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	=	Ki	nM	158.49	CHEMBL4516	Homo sapiens	pKi		6.8
inactive	9510933	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510934	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	=	Ki	nM	794.33	CHEMBL4516	Homo sapiens	pKi		6.1
active	9510935	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	=	Ki	nM	1584.89	CHEMBL4516	Homo sapiens	pKi		5.8
inactive	9510936	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510937	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510938	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	=	Ki	nM	3162.28	CHEMBL4516	Homo sapiens	pKi		5.5
active	9510939	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	7.943	CHEMBL4516	Homo sapiens	pKi		8.1
inactive	9510940	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510941	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510942	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	50.12	CHEMBL4516	Homo sapiens	pKi		7.3
active	9510943	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
active	9510944	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9510945	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510946	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510947	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510948	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510949	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	3162.28	CHEMBL4516	Homo sapiens	pKi		5.5
inactive	9510950	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510951	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510952	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510953	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510954	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	251.19	CHEMBL4516	Homo sapiens	pKi		6.6
active	9510955	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	=	Ki	nM	100.0	CHEMBL4516	Homo sapiens	pKi		7.0
active	9510956	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9510957	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510958	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510959	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510960	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510961	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510962	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	316.23	CHEMBL4516	Homo sapiens	pKi		6.5
inactive	9510963	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510964	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510965	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510966	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510967	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9510968	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510969	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	=	Ki	nM	1995.26	CHEMBL4516	Homo sapiens	pKi		5.7
inactive	9510970	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510971	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510972	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510973	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510974	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510975	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510976	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	3162.28	CHEMBL4516	Homo sapiens	pKi		5.5
inactive	9510977	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510978	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	15.85	CHEMBL4516	Homo sapiens	pKi		7.8
inactive	9510979	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510980	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	1995.26	CHEMBL4516	Homo sapiens	pKi		5.7
inactive	9510981	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510982	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	251.19	CHEMBL4516	Homo sapiens	pKi		6.6
inactive	9510983	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510984	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	=	Ki	nM	79.43	CHEMBL4516	Homo sapiens	pKi		7.1
active	9510985	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9510986	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510987	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	50.12	CHEMBL4516	Homo sapiens	pKi		7.3
inactive	9510988	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510989	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9510990	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9510991	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510992	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510993	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510994	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510995	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCNNc1cc(C)c(C#N)c2nc3ccccc3n12		CHEMBL2000433	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510996	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510997	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510998	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9510999	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511000	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9511001	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511002	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511003	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511004	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511005	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511006	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511007	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511008	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511009	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511010	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511011	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	=	Ki	nM	2511.89	CHEMBL4516	Homo sapiens	pKi		5.6
inactive	9511012	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511013	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511014	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511015	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511016	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1NC(=O)C(Nc2ccccc2)=C1Cl		CHEMBL2007138	<	Ki	nM	25118.86	CHEMBL4516	Homo sapiens	pKi		4.6
inactive	9511017	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511018	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511019	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1		CHEMBL1965351	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511020	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511021	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511022	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511023	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511024	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511025	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511026	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511027	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	501.19	CHEMBL4516	Homo sapiens	pKi		6.3
inactive	9511028	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	<	Ki	nM	25118.86	CHEMBL4516	Homo sapiens	pKi		4.6
inactive	9511029	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511030	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511031	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511032	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	199.53	CHEMBL4516	Homo sapiens	pKi		6.7
inactive	9511033	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511034	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511035	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511036	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511037	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9511038	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511039	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511040	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511041	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
active	9511042	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	501.19	CHEMBL4516	Homo sapiens	pKi		6.3
inactive	9511043	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511044	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511045	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511046	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511047	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511048	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9511049	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511050	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	=	Ki	nM	100.0	CHEMBL4516	Homo sapiens	pKi		7.0
active	9511051	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	1258.93	CHEMBL4516	Homo sapiens	pKi		5.9
active	9511052	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	=	Ki	nM	630.96	CHEMBL4516	Homo sapiens	pKi		6.2
inactive	9511053	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511054	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511055	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511056	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511057	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511058	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511059	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(c1ccccc1CNc1nc(N)nc2[nH]ccc12)S(C)(=O)=O		CHEMBL1970006	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511060	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511061	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511062	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511063	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	=	Ki	nM	1258.93	CHEMBL4516	Homo sapiens	pKi		5.9
inactive	9511064	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511065	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511066	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511067	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	=	Ki	nM	3162.28	CHEMBL4516	Homo sapiens	pKi		5.5
inactive	9511068	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511069	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	31.62	CHEMBL4516	Homo sapiens	pKi		7.5
inactive	9511070	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511071	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511072	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511073	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511074	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511075	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	1584.89	CHEMBL4516	Homo sapiens	pKi		5.8
inactive	9511076	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511077	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511078	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511079	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511080	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511081	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	7.943	CHEMBL4516	Homo sapiens	pKi		8.1
active	9511082	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	=	Ki	nM	316.23	CHEMBL4516	Homo sapiens	pKi		6.5
inactive	9511083	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511084	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511085	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511086	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511087	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	79.43	CHEMBL4516	Homo sapiens	pKi		7.1
inactive	9511088	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511089	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511090	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511091	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511092	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511093	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511094	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511095	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9511096	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511097	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511098	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511099	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511100	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	39.81	CHEMBL4516	Homo sapiens	pKi		7.4
inactive	9511101	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511102	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	=	Ki	nM	316.23	CHEMBL4516	Homo sapiens	pKi		6.5
inactive	9511103	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	<	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9511104	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511105	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511106	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511107	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511108	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511109	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511110	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511111	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511112	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511113	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511114	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511115	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511116	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511117	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	=	Ki	nM	63.1	CHEMBL4516	Homo sapiens	pKi		7.2
inactive	9511118	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511119	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9511120	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511121	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511122	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511123	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511124	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511125	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	=	Ki	nM	251.19	CHEMBL4516	Homo sapiens	pKi		6.6
inactive	9511126	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511127	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511128	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	=	Ki	nM	2511.89	CHEMBL4516	Homo sapiens	pKi		5.6
active	9511129	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
active	9511130	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9511131	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511132	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	199.53	CHEMBL4516	Homo sapiens	pKi		6.7
inactive	9511133	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1c2c([nH]c3cc(-c4ccco4)nn13)CSC2		CHEMBL1972152	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511134	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511135	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511136	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(CN2CCCCC2)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL202635	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511137	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511138	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511139	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511140	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511141	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511142	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511143	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511144	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511145	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511146	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511147	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9511148	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9511149	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511150	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511151	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511152	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511153	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9511154	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9515067	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
active	9515068	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	=	Ki	nM	398.11	CHEMBL4516	Homo sapiens	pKi		6.4
inactive	9515069	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515070	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515071	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515072	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515073	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515074	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515075	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9515076	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	1584.89	CHEMBL4516	Homo sapiens	pKi		5.8
inactive	9515077	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515078	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9515079	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9515080	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515081	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515082	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9515083	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9515084	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515085	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515086	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515087	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515088	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9515089	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	100.0	CHEMBL4516	Homo sapiens	pKi		7.0
active	9515090	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	1995.26	CHEMBL4516	Homo sapiens	pKi		5.7
inactive	9515091	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515092	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515093	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9515094	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9564799	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
active	9568717	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	=	Ki	nM	794.33	CHEMBL4516	Homo sapiens	pKi		6.1
inactive	9568718	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568719	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	=	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568720	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568721	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9568722	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568723	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568724	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	<	Ki	nM	25118.86	CHEMBL4516	Homo sapiens	pKi		4.6
active	9568725	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9568726	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568727	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	501.19	CHEMBL4516	Homo sapiens	pKi		6.3
inactive	9568728	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568729	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568730	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568731	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	199.53	CHEMBL4516	Homo sapiens	pKi		6.7
inactive	9568732	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568733	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	63.1	CHEMBL4516	Homo sapiens	pKi		7.2
active	9568734	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	=	Ki	nM	398.11	CHEMBL4516	Homo sapiens	pKi		6.4
active	9568735	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9568736	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568737	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568738	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9568739	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568740	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568741	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568742	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568743	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	31.62	CHEMBL4516	Homo sapiens	pKi		7.5
inactive	9568744	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568745	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccccc1-c1cccc2c1c(Nc1ccccc1)c(C(=O)O)n2CCCOc1cccc2ccccc12		CHEMBL2001646	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
active	9568746	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	=	Ki	nM	2511.89	CHEMBL4516	Homo sapiens	pKi		5.6
inactive	9568747	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568748	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568749	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568750	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568751	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9568752	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568753	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9568754	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568755	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568756	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568757	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568758	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568759	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568760	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	1258.93	CHEMBL4516	Homo sapiens	pKi		5.9
active	9568761	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	251.19	CHEMBL4516	Homo sapiens	pKi		6.6
inactive	9568762	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568763	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(OC)c(CNC(=O)c2cc(N)c(C#N)c(OC(C)C)n2)c1		CHEMBL1982541	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568764	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568765	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	=	Ki	nM	199.53	CHEMBL4516	Homo sapiens	pKi		6.7
inactive	9568766	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568767	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568768	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568769	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568770	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9568771	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568772	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568773	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568774	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
active	9568775	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	7.943	CHEMBL4516	Homo sapiens	pKi		8.1
inactive	9568776	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568777	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568778	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1OC		CHEMBL1996604	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568779	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568780	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568781	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568782	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568783	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568784	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568785	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568786	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568787	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	1584.89	CHEMBL4516	Homo sapiens	pKi		5.8
inactive	9568788	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568789	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568790	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568791	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568792	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568793	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568794	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568795	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568796	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568797	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568798	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	=	Ki	nM	1584.89	CHEMBL4516	Homo sapiens	pKi		5.8
active	9568799	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1C(F)(F)F		CHEMBL1981947	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
active	9568800	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	251.19	CHEMBL4516	Homo sapiens	pKi		6.6
inactive	9568801	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568802	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568803	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568804	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
active	9568805	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9568806	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568807	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568808	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568809	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568810	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	=	Ki	nM	100.0	CHEMBL4516	Homo sapiens	pKi		7.0
inactive	9568811	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568812	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568813	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568814	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568815	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568816	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
inactive	9568817	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568818	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568819	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568820	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568821	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9568822	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568823	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	158.49	CHEMBL4516	Homo sapiens	pKi		6.8
inactive	9568824	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568825	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	=	Ki	nM	3162.28	CHEMBL4516	Homo sapiens	pKi		5.5
inactive	9568826	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568827	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568828	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568829	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
active	9568830	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9568831	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568832	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568833	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=NNC(=O)c1nnn(-c2nonc2N)c1-c1ccccc1)c1ccco1		CHEMBL1890036	=	Ki	nM	794.33	CHEMBL4516	Homo sapiens	pKi		6.1
active	9568834	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC1CCCN1CCc1cc2cc(-c3ccc(OC(F)(F)F)cc3)ccc2[nH]1		CHEMBL1990635	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
active	9568835	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	3981.07	CHEMBL4516	Homo sapiens	pKi		5.4
inactive	9568836	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568837	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	=	Ki	nM	3162.28	CHEMBL4516	Homo sapiens	pKi		5.5
inactive	9568838	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568839	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568840	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568841	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568842	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568843	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568844	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	=	Ki	nM	1258.93	CHEMBL4516	Homo sapiens	pKi		5.9
inactive	9568845	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568846	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568847	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568848	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9568849	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568850	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	=	Ki	nM	3162.28	CHEMBL4516	Homo sapiens	pKi		5.5
active	9568851	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	199.53	CHEMBL4516	Homo sapiens	pKi		6.7
inactive	9568852	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568853	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568854	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568855	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568856	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568857	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568858	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568859	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568860	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568861	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568862	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568863	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568864	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	31.62	CHEMBL4516	Homo sapiens	pKi		7.5
active	9568865	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	=	Ki	nM	1258.93	CHEMBL4516	Homo sapiens	pKi		5.9
active	9568866	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
active	9568867	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
active	9568868	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	79.43	CHEMBL4516	Homo sapiens	pKi		7.1
active	9568869	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	630.96	CHEMBL4516	Homo sapiens	pKi		6.2
active	9568870	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9568871	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568872	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	=	Ki	nM	1995.26	CHEMBL4516	Homo sapiens	pKi		5.7
inactive	9568873	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568874	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568875	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568876	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568877	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568878	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568879	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568880	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	=	Ki	nM	125.89	CHEMBL4516	Homo sapiens	pKi		6.9
inactive	9568881	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568882	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568883	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568884	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568885	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	1000.0	CHEMBL4516	Homo sapiens	pKi		6.0
inactive	9568886	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568887	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9568888	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568889	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9568890	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568891	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568892	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568893	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568894	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	=	Ki	nM	2511.89	CHEMBL4516	Homo sapiens	pKi		5.6
inactive	9568895	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568896	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)c1ccc2c(c1)c(SC(C)(C)C)c(CC(C)(C)CNCCCO)n2Cc1ccc(Cl)cc1		CHEMBL1977294	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
active	9568897	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	2511.89	CHEMBL4516	Homo sapiens	pKi		5.6
active	9568898	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	=	Ki	nM	501.19	CHEMBL4516	Homo sapiens	pKi		6.3
inactive	9568899	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568900	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
active	9568901	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
active	9568902	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	=	Ki	nM	1258.93	CHEMBL4516	Homo sapiens	pKi		5.9
inactive	9568903	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568904	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568905	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Nc1ccc(CO)cc1)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1974363	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568906	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568907	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568908	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568909	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	=	Ki	nM	79.43	CHEMBL4516	Homo sapiens	pKi		7.1
inactive	9568910	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568911	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568912	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568913	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568914	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568915	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	1258.93	CHEMBL4516	Homo sapiens	pKi		5.9
inactive	9568916	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cccc2[nH]c(-c3cccc(NCCN4CCCC4)n3)nc12		CHEMBL1985309	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568917	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568918	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568919	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568920	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568921	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568922	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9568923	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568924	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568925	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568926	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568927	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568928	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	3.981	CHEMBL4516	Homo sapiens	pKi		8.4
active	9568929	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9568930	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568931	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568932	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9568933	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568934	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	6309.57	CHEMBL4516	Homo sapiens	pKi		5.2
inactive	9568935	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568936	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568937	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	=	Ki	nM	794.33	CHEMBL4516	Homo sapiens	pKi		6.1
inactive	9568938	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1nsc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL2002553	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568939	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568940	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568941	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568942	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
inactive	9568943	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568944	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	=	Ki	nM	1584.89	CHEMBL4516	Homo sapiens	pKi		5.8
inactive	9568945	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568946	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568947	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568948	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568949	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568950	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	=	Ki	nM	63.1	CHEMBL4516	Homo sapiens	pKi		7.2
inactive	9568951	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568952	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568953	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568954	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568955	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568956	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568957	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	=	Ki	nM	5011.87	CHEMBL4516	Homo sapiens	pKi		5.3
active	9568958	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	=	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
inactive	9568959	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	10000.0	CHEMBL4516	Homo sapiens	pKi		5.0
active	9568960	CHEMBL1964102	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	=	Ki	nM	7943.28	CHEMBL4516	Homo sapiens	pKi		5.1
	10839409	CHEMBL2015071	Inhibition of MRCKa at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	18.0	CHEMBL4516	Homo sapiens	INH	%	18.0
	12046366	CHEMBL2157293	Inhibition of MRCKalpha at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-4.1	CHEMBL4516	Homo sapiens	INH	%	-4.1
	12172336	CHEMBL2215899	Inhibition of MRCKA assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	56.0	CHEMBL4516	Homo sapiens	Activity	%	56.0
	12234928	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	108.0	CHEMBL4516	Homo sapiens	Residual Activity	%	108.0
	12234929	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	96.0	CHEMBL4516	Homo sapiens	Residual Activity	%	96.0
	12234930	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	92.0	CHEMBL4516	Homo sapiens	Residual Activity	%	92.0
	12234931	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	116.0	CHEMBL4516	Homo sapiens	Residual Activity	%	116.0
	12234932	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	98.0	CHEMBL4516	Homo sapiens	Residual Activity	%	98.0
	12234933	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	111.0	CHEMBL4516	Homo sapiens	Residual Activity	%	111.0
	12234934	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	103.0	CHEMBL4516	Homo sapiens	Residual Activity	%	103.0
	12234935	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	107.0	CHEMBL4516	Homo sapiens	Residual Activity	%	107.0
	12234936	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	116.0	CHEMBL4516	Homo sapiens	Residual Activity	%	116.0
	12234937	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	105.0	CHEMBL4516	Homo sapiens	Residual Activity	%	105.0
	12234938	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	98.0	CHEMBL4516	Homo sapiens	Residual Activity	%	98.0
	12234939	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	96.0	CHEMBL4516	Homo sapiens	Residual Activity	%	96.0
	12234940	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	109.0	CHEMBL4516	Homo sapiens	Residual Activity	%	109.0
	12234941	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	95.0	CHEMBL4516	Homo sapiens	Residual Activity	%	95.0
	12234942	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	104.0	CHEMBL4516	Homo sapiens	Residual Activity	%	104.0
	12234943	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	104.0	CHEMBL4516	Homo sapiens	Residual Activity	%	104.0
	12234944	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12234945	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	85.0	CHEMBL4516	Homo sapiens	Residual Activity	%	85.0
	12234946	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	92.0	CHEMBL4516	Homo sapiens	Residual Activity	%	92.0
	12234947	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	86.0	CHEMBL4516	Homo sapiens	Residual Activity	%	86.0
	12234948	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	102.0	CHEMBL4516	Homo sapiens	Residual Activity	%	102.0
	12234949	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	100.0	CHEMBL4516	Homo sapiens	Residual Activity	%	100.0
	12234950	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	106.0	CHEMBL4516	Homo sapiens	Residual Activity	%	106.0
	12234951	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	104.0	CHEMBL4516	Homo sapiens	Residual Activity	%	104.0
	12234952	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	86.0	CHEMBL4516	Homo sapiens	Residual Activity	%	86.0
	12234953	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	88.0	CHEMBL4516	Homo sapiens	Residual Activity	%	88.0
	12234954	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	85.0	CHEMBL4516	Homo sapiens	Residual Activity	%	85.0
	12234955	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	82.0	CHEMBL4516	Homo sapiens	Residual Activity	%	82.0
	12234956	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	109.0	CHEMBL4516	Homo sapiens	Residual Activity	%	109.0
	12234957	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12234958	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	102.0	CHEMBL4516	Homo sapiens	Residual Activity	%	102.0
	12234959	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	116.0	CHEMBL4516	Homo sapiens	Residual Activity	%	116.0
	12234960	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	122.0	CHEMBL4516	Homo sapiens	Residual Activity	%	122.0
	12234961	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	105.0	CHEMBL4516	Homo sapiens	Residual Activity	%	105.0
	12234962	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	102.0	CHEMBL4516	Homo sapiens	Residual Activity	%	102.0
	12234963	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12234964	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	116.0	CHEMBL4516	Homo sapiens	Residual Activity	%	116.0
	12234965	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	118.0	CHEMBL4516	Homo sapiens	Residual Activity	%	118.0
	12234966	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	113.0	CHEMBL4516	Homo sapiens	Residual Activity	%	113.0
	12234967	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	108.0	CHEMBL4516	Homo sapiens	Residual Activity	%	108.0
	12234968	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	133.0	CHEMBL4516	Homo sapiens	Residual Activity	%	133.0
	12234969	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	105.0	CHEMBL4516	Homo sapiens	Residual Activity	%	105.0
	12234970	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	87.0	CHEMBL4516	Homo sapiens	Residual Activity	%	87.0
	12234971	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	95.0	CHEMBL4516	Homo sapiens	Residual Activity	%	95.0
	12234972	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	109.0	CHEMBL4516	Homo sapiens	Residual Activity	%	109.0
	12234973	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	113.0	CHEMBL4516	Homo sapiens	Residual Activity	%	113.0
	12234974	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	97.0	CHEMBL4516	Homo sapiens	Residual Activity	%	97.0
	12234975	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	119.0	CHEMBL4516	Homo sapiens	Residual Activity	%	119.0
	12234976	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	107.0	CHEMBL4516	Homo sapiens	Residual Activity	%	107.0
	12234977	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	97.0	CHEMBL4516	Homo sapiens	Residual Activity	%	97.0
	12234978	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	74.0	CHEMBL4516	Homo sapiens	Residual Activity	%	74.0
	12234979	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	107.0	CHEMBL4516	Homo sapiens	Residual Activity	%	107.0
	12234980	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	104.0	CHEMBL4516	Homo sapiens	Residual Activity	%	104.0
	12234981	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	98.0	CHEMBL4516	Homo sapiens	Residual Activity	%	98.0
	12234982	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	95.0	CHEMBL4516	Homo sapiens	Residual Activity	%	95.0
	12234983	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	116.0	CHEMBL4516	Homo sapiens	Residual Activity	%	116.0
	12234984	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	105.0	CHEMBL4516	Homo sapiens	Residual Activity	%	105.0
	12234985	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	107.0	CHEMBL4516	Homo sapiens	Residual Activity	%	107.0
	12234986	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	92.0	CHEMBL4516	Homo sapiens	Residual Activity	%	92.0
	12234987	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	85.0	CHEMBL4516	Homo sapiens	Residual Activity	%	85.0
	12234988	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12234989	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	93.0	CHEMBL4516	Homo sapiens	Residual Activity	%	93.0
	12234990	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	90.0	CHEMBL4516	Homo sapiens	Residual Activity	%	90.0
	12234991	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	100.0	CHEMBL4516	Homo sapiens	Residual Activity	%	100.0
	12234992	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	127.0	CHEMBL4516	Homo sapiens	Residual Activity	%	127.0
	12234993	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	113.0	CHEMBL4516	Homo sapiens	Residual Activity	%	113.0
	12234994	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	114.0	CHEMBL4516	Homo sapiens	Residual Activity	%	114.0
	12234995	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	86.0	CHEMBL4516	Homo sapiens	Residual Activity	%	86.0
	12234996	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	106.0	CHEMBL4516	Homo sapiens	Residual Activity	%	106.0
	12234997	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	103.0	CHEMBL4516	Homo sapiens	Residual Activity	%	103.0
	12234998	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	114.0	CHEMBL4516	Homo sapiens	Residual Activity	%	114.0
	12234999	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	117.0	CHEMBL4516	Homo sapiens	Residual Activity	%	117.0
	12235000	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	115.0	CHEMBL4516	Homo sapiens	Residual Activity	%	115.0
	12235001	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	121.0	CHEMBL4516	Homo sapiens	Residual Activity	%	121.0
	12235002	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	107.0	CHEMBL4516	Homo sapiens	Residual Activity	%	107.0
	12235003	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	110.0	CHEMBL4516	Homo sapiens	Residual Activity	%	110.0
	12235004	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	112.0	CHEMBL4516	Homo sapiens	Residual Activity	%	112.0
	12235005	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	118.0	CHEMBL4516	Homo sapiens	Residual Activity	%	118.0
	12235006	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	121.0	CHEMBL4516	Homo sapiens	Residual Activity	%	121.0
	12235007	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL4516	Homo sapiens	Residual Activity	%	1.0
	12235008	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12235009	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	97.0	CHEMBL4516	Homo sapiens	Residual Activity	%	97.0
	12235010	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	87.0	CHEMBL4516	Homo sapiens	Residual Activity	%	87.0
	12235011	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	98.0	CHEMBL4516	Homo sapiens	Residual Activity	%	98.0
	12235012	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	111.0	CHEMBL4516	Homo sapiens	Residual Activity	%	111.0
	12235013	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	107.0	CHEMBL4516	Homo sapiens	Residual Activity	%	107.0
	12235014	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	105.0	CHEMBL4516	Homo sapiens	Residual Activity	%	105.0
	12235015	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	106.0	CHEMBL4516	Homo sapiens	Residual Activity	%	106.0
	12235016	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	110.0	CHEMBL4516	Homo sapiens	Residual Activity	%	110.0
	12235017	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	142.0	CHEMBL4516	Homo sapiens	Residual Activity	%	142.0
	12235018	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	119.0	CHEMBL4516	Homo sapiens	Residual Activity	%	119.0
	12235019	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	111.0	CHEMBL4516	Homo sapiens	Residual Activity	%	111.0
	12235020	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	122.0	CHEMBL4516	Homo sapiens	Residual Activity	%	122.0
	12237630	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	113.0	CHEMBL4516	Homo sapiens	Residual Activity	%	113.0
	12237631	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	119.0	CHEMBL4516	Homo sapiens	Residual Activity	%	119.0
	12237632	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	114.0	CHEMBL4516	Homo sapiens	Residual Activity	%	114.0
	12237633	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	106.0	CHEMBL4516	Homo sapiens	Residual Activity	%	106.0
	12237634	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	86.0	CHEMBL4516	Homo sapiens	Residual Activity	%	86.0
	12237635	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	95.0	CHEMBL4516	Homo sapiens	Residual Activity	%	95.0
	12237636	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	94.0	CHEMBL4516	Homo sapiens	Residual Activity	%	94.0
	12237637	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12237638	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	71.0	CHEMBL4516	Homo sapiens	Residual Activity	%	71.0
	12237639	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	118.0	CHEMBL4516	Homo sapiens	Residual Activity	%	118.0
	12237640	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	116.0	CHEMBL4516	Homo sapiens	Residual Activity	%	116.0
	12237641	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	60.0	CHEMBL4516	Homo sapiens	Residual Activity	%	60.0
	12237642	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	86.0	CHEMBL4516	Homo sapiens	Residual Activity	%	86.0
	12237643	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	94.0	CHEMBL4516	Homo sapiens	Residual Activity	%	94.0
	12237644	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	100.0	CHEMBL4516	Homo sapiens	Residual Activity	%	100.0
	12237645	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	117.0	CHEMBL4516	Homo sapiens	Residual Activity	%	117.0
	12237646	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	103.0	CHEMBL4516	Homo sapiens	Residual Activity	%	103.0
	12237647	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	126.0	CHEMBL4516	Homo sapiens	Residual Activity	%	126.0
	12237648	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	114.0	CHEMBL4516	Homo sapiens	Residual Activity	%	114.0
	12237649	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	35.0	CHEMBL4516	Homo sapiens	Residual Activity	%	35.0
	12237650	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	106.0	CHEMBL4516	Homo sapiens	Residual Activity	%	106.0
	12237651	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	113.0	CHEMBL4516	Homo sapiens	Residual Activity	%	113.0
	12237652	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	98.0	CHEMBL4516	Homo sapiens	Residual Activity	%	98.0
	12237653	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	111.0	CHEMBL4516	Homo sapiens	Residual Activity	%	111.0
	12237654	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	119.0	CHEMBL4516	Homo sapiens	Residual Activity	%	119.0
	12237655	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	113.0	CHEMBL4516	Homo sapiens	Residual Activity	%	113.0
	12237656	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	120.0	CHEMBL4516	Homo sapiens	Residual Activity	%	120.0
	12237657	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	113.0	CHEMBL4516	Homo sapiens	Residual Activity	%	113.0
	12237658	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	109.0	CHEMBL4516	Homo sapiens	Residual Activity	%	109.0
	12237659	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	108.0	CHEMBL4516	Homo sapiens	Residual Activity	%	108.0
	12237660	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	123.0	CHEMBL4516	Homo sapiens	Residual Activity	%	123.0
	12237661	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	111.0	CHEMBL4516	Homo sapiens	Residual Activity	%	111.0
	12237662	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	111.0	CHEMBL4516	Homo sapiens	Residual Activity	%	111.0
	12237663	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	112.0	CHEMBL4516	Homo sapiens	Residual Activity	%	112.0
	12237664	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	118.0	CHEMBL4516	Homo sapiens	Residual Activity	%	118.0
	12237665	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	98.0	CHEMBL4516	Homo sapiens	Residual Activity	%	98.0
	12237666	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	28.0	CHEMBL4516	Homo sapiens	Residual Activity	%	28.0
	12237667	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	108.0	CHEMBL4516	Homo sapiens	Residual Activity	%	108.0
	12237668	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	118.0	CHEMBL4516	Homo sapiens	Residual Activity	%	118.0
	12237669	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	115.0	CHEMBL4516	Homo sapiens	Residual Activity	%	115.0
	12237670	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	104.0	CHEMBL4516	Homo sapiens	Residual Activity	%	104.0
	12237671	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	123.0	CHEMBL4516	Homo sapiens	Residual Activity	%	123.0
	12237672	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	122.0	CHEMBL4516	Homo sapiens	Residual Activity	%	122.0
	12237673	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12237674	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12237675	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	141.0	CHEMBL4516	Homo sapiens	Residual Activity	%	141.0
	12237676	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	108.0	CHEMBL4516	Homo sapiens	Residual Activity	%	108.0
	12237677	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	107.0	CHEMBL4516	Homo sapiens	Residual Activity	%	107.0
	12237678	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	109.0	CHEMBL4516	Homo sapiens	Residual Activity	%	109.0
	12237679	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	107.0	CHEMBL4516	Homo sapiens	Residual Activity	%	107.0
	12237680	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	121.0	CHEMBL4516	Homo sapiens	Residual Activity	%	121.0
	12237681	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	106.0	CHEMBL4516	Homo sapiens	Residual Activity	%	106.0
	12237682	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	106.0	CHEMBL4516	Homo sapiens	Residual Activity	%	106.0
	12237683	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	93.0	CHEMBL4516	Homo sapiens	Residual Activity	%	93.0
	12237684	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	114.0	CHEMBL4516	Homo sapiens	Residual Activity	%	114.0
	12237685	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	117.0	CHEMBL4516	Homo sapiens	Residual Activity	%	117.0
	12237686	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	115.0	CHEMBL4516	Homo sapiens	Residual Activity	%	115.0
	12237687	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	129.0	CHEMBL4516	Homo sapiens	Residual Activity	%	129.0
	12237688	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	109.0	CHEMBL4516	Homo sapiens	Residual Activity	%	109.0
	12237689	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	108.0	CHEMBL4516	Homo sapiens	Residual Activity	%	108.0
	12237690	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	110.0	CHEMBL4516	Homo sapiens	Residual Activity	%	110.0
	12237691	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	105.0	CHEMBL4516	Homo sapiens	Residual Activity	%	105.0
	12237692	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	131.0	CHEMBL4516	Homo sapiens	Residual Activity	%	131.0
	12237693	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	116.0	CHEMBL4516	Homo sapiens	Residual Activity	%	116.0
	12237694	CHEMBL2219275	Millipore: Percentage of residual kinase activity of CDC42BPA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	14.0	CHEMBL4516	Homo sapiens	Residual Activity	%	14.0
	12237695	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	91.0	CHEMBL4516	Homo sapiens	Residual Activity	%	91.0
	12237696	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	106.0	CHEMBL4516	Homo sapiens	Residual Activity	%	106.0
	12237697	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	115.0	CHEMBL4516	Homo sapiens	Residual Activity	%	115.0
	12237698	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	108.0	CHEMBL4516	Homo sapiens	Residual Activity	%	108.0
	12237699	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	101.0	CHEMBL4516	Homo sapiens	Residual Activity	%	101.0
	12237700	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	103.0	CHEMBL4516	Homo sapiens	Residual Activity	%	103.0
	12237701	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	89.0	CHEMBL4516	Homo sapiens	Residual Activity	%	89.0
	12237702	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	111.0	CHEMBL4516	Homo sapiens	Residual Activity	%	111.0
	12237703	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	102.0	CHEMBL4516	Homo sapiens	Residual Activity	%	102.0
	12237704	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	87.0	CHEMBL4516	Homo sapiens	Residual Activity	%	87.0
	12237705	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	87.0	CHEMBL4516	Homo sapiens	Residual Activity	%	87.0
	12237706	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	110.0	CHEMBL4516	Homo sapiens	Residual Activity	%	110.0
	12237707	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	101.0	CHEMBL4516	Homo sapiens	Residual Activity	%	101.0
	12237708	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	119.0	CHEMBL4516	Homo sapiens	Residual Activity	%	119.0
	12237709	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	105.0	CHEMBL4516	Homo sapiens	Residual Activity	%	105.0
	12237710	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	102.0	CHEMBL4516	Homo sapiens	Residual Activity	%	102.0
	12237711	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	122.0	CHEMBL4516	Homo sapiens	Residual Activity	%	122.0
	12237712	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	84.0	CHEMBL4516	Homo sapiens	Residual Activity	%	84.0
	12237713	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	85.0	CHEMBL4516	Homo sapiens	Residual Activity	%	85.0
	12237714	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	75.0	CHEMBL4516	Homo sapiens	Residual Activity	%	75.0
	12237715	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	102.0	CHEMBL4516	Homo sapiens	Residual Activity	%	102.0
	12237716	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	111.0	CHEMBL4516	Homo sapiens	Residual Activity	%	111.0
	12237717	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	100.0	CHEMBL4516	Homo sapiens	Residual Activity	%	100.0
	12237718	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	107.0	CHEMBL4516	Homo sapiens	Residual Activity	%	107.0
	12237719	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	93.0	CHEMBL4516	Homo sapiens	Residual Activity	%	93.0
	12237720	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12237721	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	78.0	CHEMBL4516	Homo sapiens	Residual Activity	%	78.0
	12237722	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	84.0	CHEMBL4516	Homo sapiens	Residual Activity	%	84.0
	12237723	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	139.0	CHEMBL4516	Homo sapiens	Residual Activity	%	139.0
	12237724	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	89.0	CHEMBL4516	Homo sapiens	Residual Activity	%	89.0
	12237725	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	100.0	CHEMBL4516	Homo sapiens	Residual Activity	%	100.0
	12237726	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	102.0	CHEMBL4516	Homo sapiens	Residual Activity	%	102.0
	12237727	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	128.0	CHEMBL4516	Homo sapiens	Residual Activity	%	128.0
	12237728	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12237729	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	76.0	CHEMBL4516	Homo sapiens	Residual Activity	%	76.0
	12237730	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	96.0	CHEMBL4516	Homo sapiens	Residual Activity	%	96.0
	12237731	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	129.0	CHEMBL4516	Homo sapiens	Residual Activity	%	129.0
	12237732	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	146.0	CHEMBL4516	Homo sapiens	Residual Activity	%	146.0
	12237733	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	82.0	CHEMBL4516	Homo sapiens	Residual Activity	%	82.0
	12237734	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	110.0	CHEMBL4516	Homo sapiens	Residual Activity	%	110.0
	12237735	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	119.0	CHEMBL4516	Homo sapiens	Residual Activity	%	119.0
	12237736	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	92.0	CHEMBL4516	Homo sapiens	Residual Activity	%	92.0
	12237737	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	79.0	CHEMBL4516	Homo sapiens	Residual Activity	%	79.0
	12237738	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	52.0	CHEMBL4516	Homo sapiens	Residual Activity	%	52.0
	12237739	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	124.0	CHEMBL4516	Homo sapiens	Residual Activity	%	124.0
	12237740	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	85.0	CHEMBL4516	Homo sapiens	Residual Activity	%	85.0
	12237741	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	85.0	CHEMBL4516	Homo sapiens	Residual Activity	%	85.0
	12237742	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	115.0	CHEMBL4516	Homo sapiens	Residual Activity	%	115.0
	12237743	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	100.0	CHEMBL4516	Homo sapiens	Residual Activity	%	100.0
	12237744	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	91.0	CHEMBL4516	Homo sapiens	Residual Activity	%	91.0
	12237745	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	80.0	CHEMBL4516	Homo sapiens	Residual Activity	%	80.0
	12237746	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	118.0	CHEMBL4516	Homo sapiens	Residual Activity	%	118.0
	12237747	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	90.0	CHEMBL4516	Homo sapiens	Residual Activity	%	90.0
	12237748	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12237749	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	87.0	CHEMBL4516	Homo sapiens	Residual Activity	%	87.0
	12237750	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12237751	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	116.0	CHEMBL4516	Homo sapiens	Residual Activity	%	116.0
	12237752	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	103.0	CHEMBL4516	Homo sapiens	Residual Activity	%	103.0
	12237753	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	116.0	CHEMBL4516	Homo sapiens	Residual Activity	%	116.0
	12237754	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	84.0	CHEMBL4516	Homo sapiens	Residual Activity	%	84.0
	12237755	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	96.0	CHEMBL4516	Homo sapiens	Residual Activity	%	96.0
	12237756	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	102.0	CHEMBL4516	Homo sapiens	Residual Activity	%	102.0
	12237757	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	76.0	CHEMBL4516	Homo sapiens	Residual Activity	%	76.0
	12237758	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	100.0	CHEMBL4516	Homo sapiens	Residual Activity	%	100.0
	12237759	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	145.0	CHEMBL4516	Homo sapiens	Residual Activity	%	145.0
	12237760	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	105.0	CHEMBL4516	Homo sapiens	Residual Activity	%	105.0
	12237761	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	92.0	CHEMBL4516	Homo sapiens	Residual Activity	%	92.0
	12237762	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	102.0	CHEMBL4516	Homo sapiens	Residual Activity	%	102.0
	12237763	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	93.0	CHEMBL4516	Homo sapiens	Residual Activity	%	93.0
	12237764	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	134.0	CHEMBL4516	Homo sapiens	Residual Activity	%	134.0
	12237765	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	81.0	CHEMBL4516	Homo sapiens	Residual Activity	%	81.0
	12237766	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	130.0	CHEMBL4516	Homo sapiens	Residual Activity	%	130.0
	12237767	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	76.0	CHEMBL4516	Homo sapiens	Residual Activity	%	76.0
	12237768	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	117.0	CHEMBL4516	Homo sapiens	Residual Activity	%	117.0
	12237769	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	106.0	CHEMBL4516	Homo sapiens	Residual Activity	%	106.0
	12237770	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	113.0	CHEMBL4516	Homo sapiens	Residual Activity	%	113.0
	12237771	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	104.0	CHEMBL4516	Homo sapiens	Residual Activity	%	104.0
	12237772	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	113.0	CHEMBL4516	Homo sapiens	Residual Activity	%	113.0
	12237773	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	93.0	CHEMBL4516	Homo sapiens	Residual Activity	%	93.0
	12237774	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL4516	Homo sapiens	Residual Activity	%	0.0
	12237775	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	107.0	CHEMBL4516	Homo sapiens	Residual Activity	%	107.0
	12237776	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	84.0	CHEMBL4516	Homo sapiens	Residual Activity	%	84.0
	12237777	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	88.0	CHEMBL4516	Homo sapiens	Residual Activity	%	88.0
	12237778	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	84.0	CHEMBL4516	Homo sapiens	Residual Activity	%	84.0
	12237779	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	106.0	CHEMBL4516	Homo sapiens	Residual Activity	%	106.0
	12237780	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	136.0	CHEMBL4516	Homo sapiens	Residual Activity	%	136.0
	12237781	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	113.0	CHEMBL4516	Homo sapiens	Residual Activity	%	113.0
	12237782	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	119.0	CHEMBL4516	Homo sapiens	Residual Activity	%	119.0
	12237783	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	112.0	CHEMBL4516	Homo sapiens	Residual Activity	%	112.0
	12237784	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	135.0	CHEMBL4516	Homo sapiens	Residual Activity	%	135.0
	12237785	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	93.0	CHEMBL4516	Homo sapiens	Residual Activity	%	93.0
	12237786	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	98.0	CHEMBL4516	Homo sapiens	Residual Activity	%	98.0
	12237787	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	110.0	CHEMBL4516	Homo sapiens	Residual Activity	%	110.0
	12237788	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12237789	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	110.0	CHEMBL4516	Homo sapiens	Residual Activity	%	110.0
	12237790	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	118.0	CHEMBL4516	Homo sapiens	Residual Activity	%	118.0
	12237791	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	104.0	CHEMBL4516	Homo sapiens	Residual Activity	%	104.0
	12237792	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	95.0	CHEMBL4516	Homo sapiens	Residual Activity	%	95.0
	12237793	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	91.0	CHEMBL4516	Homo sapiens	Residual Activity	%	91.0
	12237794	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	79.0	CHEMBL4516	Homo sapiens	Residual Activity	%	79.0
	12237795	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	90.0	CHEMBL4516	Homo sapiens	Residual Activity	%	90.0
	12237796	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	23.0	CHEMBL4516	Homo sapiens	Residual Activity	%	23.0
	12237797	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	96.0	CHEMBL4516	Homo sapiens	Residual Activity	%	96.0
	12237798	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	113.0	CHEMBL4516	Homo sapiens	Residual Activity	%	113.0
	12237799	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	79.0	CHEMBL4516	Homo sapiens	Residual Activity	%	79.0
	12237800	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	83.0	CHEMBL4516	Homo sapiens	Residual Activity	%	83.0
	12237801	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	84.0	CHEMBL4516	Homo sapiens	Residual Activity	%	84.0
	12237802	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	86.0	CHEMBL4516	Homo sapiens	Residual Activity	%	86.0
	12237803	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	111.0	CHEMBL4516	Homo sapiens	Residual Activity	%	111.0
	12237804	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	107.0	CHEMBL4516	Homo sapiens	Residual Activity	%	107.0
	12237805	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	98.0	CHEMBL4516	Homo sapiens	Residual Activity	%	98.0
	12237806	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	129.0	CHEMBL4516	Homo sapiens	Residual Activity	%	129.0
	12237807	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	19.0	CHEMBL4516	Homo sapiens	Residual Activity	%	19.0
	12237808	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	110.0	CHEMBL4516	Homo sapiens	Residual Activity	%	110.0
	12237809	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	127.0	CHEMBL4516	Homo sapiens	Residual Activity	%	127.0
	12237810	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	92.0	CHEMBL4516	Homo sapiens	Residual Activity	%	92.0
	12237811	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	80.0	CHEMBL4516	Homo sapiens	Residual Activity	%	80.0
	12237812	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	113.0	CHEMBL4516	Homo sapiens	Residual Activity	%	113.0
	12237813	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	108.0	CHEMBL4516	Homo sapiens	Residual Activity	%	108.0
	12237814	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	119.0	CHEMBL4516	Homo sapiens	Residual Activity	%	119.0
	12237815	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	117.0	CHEMBL4516	Homo sapiens	Residual Activity	%	117.0
	12237816	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	112.0	CHEMBL4516	Homo sapiens	Residual Activity	%	112.0
	12237817	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	98.0	CHEMBL4516	Homo sapiens	Residual Activity	%	98.0
	12237818	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	87.0	CHEMBL4516	Homo sapiens	Residual Activity	%	87.0
	12237819	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	107.0	CHEMBL4516	Homo sapiens	Residual Activity	%	107.0
	12237820	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	111.0	CHEMBL4516	Homo sapiens	Residual Activity	%	111.0
	12237821	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	118.0	CHEMBL4516	Homo sapiens	Residual Activity	%	118.0
	12237822	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	135.0	CHEMBL4516	Homo sapiens	Residual Activity	%	135.0
	12237823	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	88.0	CHEMBL4516	Homo sapiens	Residual Activity	%	88.0
	12237824	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	24.0	CHEMBL4516	Homo sapiens	Residual Activity	%	24.0
	12237825	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	89.0	CHEMBL4516	Homo sapiens	Residual Activity	%	89.0
	12237826	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	104.0	CHEMBL4516	Homo sapiens	Residual Activity	%	104.0
	12237827	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	116.0	CHEMBL4516	Homo sapiens	Residual Activity	%	116.0
	12237828	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	94.0	CHEMBL4516	Homo sapiens	Residual Activity	%	94.0
	12237829	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	109.0	CHEMBL4516	Homo sapiens	Residual Activity	%	109.0
	12237830	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	111.0	CHEMBL4516	Homo sapiens	Residual Activity	%	111.0
	12237831	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	102.0	CHEMBL4516	Homo sapiens	Residual Activity	%	102.0
	12237832	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	73.0	CHEMBL4516	Homo sapiens	Residual Activity	%	73.0
	12237833	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	103.0	CHEMBL4516	Homo sapiens	Residual Activity	%	103.0
	12237834	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	99.0	CHEMBL4516	Homo sapiens	Residual Activity	%	99.0
	12237835	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	94.0	CHEMBL4516	Homo sapiens	Residual Activity	%	94.0
	12237836	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	103.0	CHEMBL4516	Homo sapiens	Residual Activity	%	103.0
	12237837	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	115.0	CHEMBL4516	Homo sapiens	Residual Activity	%	115.0
	12237838	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	118.0	CHEMBL4516	Homo sapiens	Residual Activity	%	118.0
	12237839	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	117.0	CHEMBL4516	Homo sapiens	Residual Activity	%	117.0
	12237840	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	102.0	CHEMBL4516	Homo sapiens	Residual Activity	%	102.0
	12237841	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	101.0	CHEMBL4516	Homo sapiens	Residual Activity	%	101.0
	12237842	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	87.0	CHEMBL4516	Homo sapiens	Residual Activity	%	87.0
	12237843	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	106.0	CHEMBL4516	Homo sapiens	Residual Activity	%	106.0
	12237844	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	114.0	CHEMBL4516	Homo sapiens	Residual Activity	%	114.0
	12237845	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	100.0	CHEMBL4516	Homo sapiens	Residual Activity	%	100.0
	12237846	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	111.0	CHEMBL4516	Homo sapiens	Residual Activity	%	111.0
	12237847	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	108.0	CHEMBL4516	Homo sapiens	Residual Activity	%	108.0
	12237848	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	102.0	CHEMBL4516	Homo sapiens	Residual Activity	%	102.0
	12237849	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	104.0	CHEMBL4516	Homo sapiens	Residual Activity	%	104.0
	12237850	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	124.0	CHEMBL4516	Homo sapiens	Residual Activity	%	124.0
	12237851	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	103.0	CHEMBL4516	Homo sapiens	Residual Activity	%	103.0
	12237852	CHEMBL2219276	Millipore: Percentage of residual kinase activity of CDC42BPA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	9.0	CHEMBL4516	Homo sapiens	Residual Activity	%	9.0
	12705450	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	CN(C)c1nc([C@@H]2CNC[C@H]2c2ccccc2)nc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333879	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	12705451	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	COc1ccc([C@@H]2CN(C)C[C@H]2c2nc3ccc(-c4cn[nH]c4)cc3c(=O)[nH]2)cc1		CHEMBL2333887	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	12705452	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	NCc1ccc(C(=O)NC(c2ccc(Cl)cc2)c2nc3ccc(-c4cn[nH]c4)cc3c(=O)[nH]2)cc1		CHEMBL2333884	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	12705453	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	CN(C)CC(=O)NC(c1ccc(Cl)cc1)c1nc2ccc(-c3cn[nH]c3)cc2c(=O)[nH]1		CHEMBL2333882	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	12705454	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	O=c1[nH]c([C@@H]2CNC[C@H]2c2ccc(Cl)cc2)nc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333898	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	12705455	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	COc1cc(-c2cn[nH]c2)cc2c(=O)[nH]c(C(N)c3cccc(Cl)c3)nc12		CHEMBL2333896	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	12705456	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	NC(c1cccc(Cl)c1)c1nc2ccc(-c3cn[nH]c3)cc2c(=O)[nH]1		CHEMBL2333894	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	12705457	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	COc1ccc(C[C@H](N)c2nc3ccc(-c4cn[nH]c4)cc3c(=O)[nH]2)cc1		CHEMBL2333909	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	12705458	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	COc1cc(-c2cn[nH]c2)cc2c(=O)[nH]c([C@H](N)Cc3cccc(F)c3)nc12		CHEMBL2333908	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	12705459	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	N[C@H](Cc1ccc(F)cc1)c1nc2ccc(-c3cn[nH]c3)cc2c(=O)[nH]1		CHEMBL2333906	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	12705460	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	N[C@@H](Cc1ccc(F)cc1)c1nc2ccc(-c3cn[nH]c3)cc2c(=O)[nH]1		CHEMBL2333905	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	12705461	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	N[C@@H](Cc1ccc(Cl)cc1)c1nc2ccc(-c3cn[nH]c3)cc2c(=O)[nH]1		CHEMBL2334293	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	12705462	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	O=c1[nH]c([C@@H]2CNC[C@H]2c2ccccc2)nc2ccc(-c3cn[nH]c3)cc12		CHEMBL2334292	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
	12705463	CHEMBL2346252	Inhibition of MRCKalpha (unknown origin)	B	COc1ccc(C(N)c2nc3ccc(-c4cn[nH]c4)cc3c(=O)[nH]2)cc1		CHEMBL2334288	>	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	uM	1.0
Not Determined	12705821	CHEMBL2341179	Inhibition of MRCKalpha (unknown origin) using LCD-AKRRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay in presence of [33P]ATP	B	COc1cccc(CN(CCN(C)C)C(=O)Nc2ccc(-c3cn[nH]c3)cn2)c1		CHEMBL2332063		IC50			CHEMBL4516	Homo sapiens	IC50		
Not Determined	12705822	CHEMBL2341179	Inhibition of MRCKalpha (unknown origin) using LCD-AKRRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay in presence of [33P]ATP	B	CN(C)CCC(NC(=O)Nc1ccc(-c2cn[nH]c2)cc1)c1ccccc1		CHEMBL2332059		IC50			CHEMBL4516	Homo sapiens	IC50		
Not Determined	12705823	CHEMBL2341179	Inhibition of MRCKalpha (unknown origin) using LCD-AKRRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay in presence of [33P]ATP	B	COc1cccc(C(CCO)NC(=O)Nc2ccc(-c3cn[nH]c3)cc2)c1		CHEMBL2332076		IC50			CHEMBL4516	Homo sapiens	IC50		
Not Determined	12705824	CHEMBL2341179	Inhibition of MRCKalpha (unknown origin) using LCD-AKRRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay in presence of [33P]ATP	B	O=C(Nc1ccc(-c2cn[nH]c2)cc1)N(CCO)Cc1ccccc1		CHEMBL2331562		IC50			CHEMBL4516	Homo sapiens	IC50		
Not Determined	12705825	CHEMBL2341179	Inhibition of MRCKalpha (unknown origin) using LCD-AKRRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay in presence of [33P]ATP	B	COc1cccc(CN(CCN2CCCCC2)C(=O)Nc2ccc(-c3cn[nH]c3)cc2)c1		CHEMBL2332073		IC50			CHEMBL4516	Homo sapiens	IC50		
Not Determined	12705826	CHEMBL2341179	Inhibition of MRCKalpha (unknown origin) using LCD-AKRRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay in presence of [33P]ATP	B	COc1cccc(CN(CCN2CCOCC2)C(=O)Nc2ccc(-c3cn[nH]c3)cc2)c1		CHEMBL2332071		IC50			CHEMBL4516	Homo sapiens	IC50		
Not Determined	12705827	CHEMBL2341179	Inhibition of MRCKalpha (unknown origin) using LCD-AKRRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay in presence of [33P]ATP	B	COc1cccc(CN(CCN2CCCC2)C(=O)Nc2ccc(-c3cn[nH]c3)cc2)c1		CHEMBL2332069		IC50			CHEMBL4516	Homo sapiens	IC50		
	12705840	CHEMBL2341179	Inhibition of MRCKalpha (unknown origin) using LCD-AKRRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay in presence of [33P]ATP	B	COc1cccc(CN(CCN(C)C)C(=O)Nc2ccc(-c3cn[nH]c3)cc2)c1		CHEMBL2332068	=	IC50	nM	8695.0	CHEMBL4516	Homo sapiens	IC50	nM	8695.0
	12705844	CHEMBL2341179	Inhibition of MRCKalpha (unknown origin) using LCD-AKRRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay in presence of [33P]ATP	B	O=C(Nc1ccc(-c2cn[nH]c2)cc1)NC(CCO)c1cccc(F)c1		CHEMBL2332056	=	IC50	nM	6400.0	CHEMBL4516	Homo sapiens	IC50	nM	6400.0
	12705847	CHEMBL2341179	Inhibition of MRCKalpha (unknown origin) using LCD-AKRRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay in presence of [33P]ATP	B	COc1cccc(CN(CCO)C(=O)Nc2ccc(-c3cn[nH]c3)cc2)c1		CHEMBL2332065	=	IC50	nM	4306.0	CHEMBL4516	Homo sapiens	IC50	nM	4306.0
	12705855	CHEMBL2341179	Inhibition of MRCKalpha (unknown origin) using LCD-AKRRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay in presence of [33P]ATP	B	COc1cccc(CN(C)C(=O)Nc2ccc(-c3cn[nH]c3)cc2)c1		CHEMBL2332097	=	IC50	nM	1853.0	CHEMBL4516	Homo sapiens	IC50	nM	1853.0
	12705858	CHEMBL2341179	Inhibition of MRCKalpha (unknown origin) using LCD-AKRRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay in presence of [33P]ATP	B	CCN(Cc1cccc(OC)c1)C(=O)Nc1ccc(-c2cn[nH]c2)cc1O[C@H]1CCN(C)C1		CHEMBL2332060	=	IC50	nM	1550.0	CHEMBL4516	Homo sapiens	IC50	nM	1550.0
	12727727	CHEMBL2351161	Inhibition of MRCKalpha (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	92.0	CHEMBL4516	Homo sapiens	Activity	%	92.0
	12729015	CHEMBL2350439	Inhibition of MRCKalpha (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	95.0	CHEMBL4516	Homo sapiens	Activity	%	95.0
	12729899	CHEMBL2349802	Inhibition of MRCKA (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	99.0	CHEMBL4516	Homo sapiens	Activity	%	99.0
	12730158	CHEMBL2351161	Inhibition of MRCKalpha (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	93.0	CHEMBL4516	Homo sapiens	Activity	%	93.0
	13327696	CHEMBL2389845	Inhibition of MRCKA (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	-2.0	CHEMBL4516	Homo sapiens	INH	%	-2.0
	13327697	CHEMBL2389845	Inhibition of MRCKA (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	-5.0	CHEMBL4516	Homo sapiens	INH	%	-5.0
	13375925	CHEMBL2405936	Inhibition of MRCKA (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	0.0	CHEMBL4516	Homo sapiens	INH	%	0.0
	13439804	CHEMBL2426949	Competitive binding affinity to MRCKA (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	13442625	CHEMBL2426949	Competitive binding affinity to MRCKA (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	13445637	CHEMBL2426949	Competitive binding affinity to MRCKA (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	13451624	CHEMBL2426949	Competitive binding affinity to MRCKA (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	13872091	CHEMBL3101275	Inhibition of human MRCKalpha assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	119.0	CHEMBL4516	Homo sapiens	Activity	%	119.0
	14545798	CHEMBL3224468	Inhibition of MRCKalpha (unknown origin) assessed as residual activity at 1 uM	B	CS(=O)(=O)O.O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL3218297	=	Activity	%	49.6	CHEMBL4516	Homo sapiens	Activity	%	49.6
	14545821	CHEMBL3224488	Inhibition of MRCKalpha (unknown origin)	B	CS(=O)(=O)O.O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL3218297	=	IC50	nM	2.87	CHEMBL4516	Homo sapiens	IC50	nM	2.87
	14549805	CHEMBL3226113	Inhibition of MRCK-alpha (unknown origin) using LCB-AKRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay	B	COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCN(C)C)CO2		CHEMBL3221807	=	IC50	nM	127.0	CHEMBL4516	Homo sapiens	IC50	nM	127.0
	14549806	CHEMBL3226113	Inhibition of MRCK-alpha (unknown origin) using LCB-AKRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay	B	COc1ccc2c(c1)C[C@@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCN(C)C)CO2		CHEMBL3221808	=	IC50	nM	8640.0	CHEMBL4516	Homo sapiens	IC50	nM	8640.0
	14549807	CHEMBL3226113	Inhibition of MRCK-alpha (unknown origin) using LCB-AKRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay	B	COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCN1CCCC1)CO2		CHEMBL3221809	=	IC50	nM	1275.0	CHEMBL4516	Homo sapiens	IC50	nM	1275.0
	14549808	CHEMBL3226113	Inhibition of MRCK-alpha (unknown origin) using LCB-AKRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay	B	COc1ccc2c(c1)C[C@@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCN1CCCC1)CO2		CHEMBL3221810	>	IC50	nM	20000.0	CHEMBL4516	Homo sapiens	IC50	nM	20000.0
	14549809	CHEMBL3226113	Inhibition of MRCK-alpha (unknown origin) using LCB-AKRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay	B	COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1O[C@@H]1CCN(C)C1)CO2		CHEMBL3221811	=	IC50	nM	261.0	CHEMBL4516	Homo sapiens	IC50	nM	261.0
	14549810	CHEMBL3226113	Inhibition of MRCK-alpha (unknown origin) using LCB-AKRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay	B	COc1ccc2c(c1)C[C@@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1O[C@@H]1CCN(C)C1)CO2		CHEMBL3221812	>	IC50	nM	20000.0	CHEMBL4516	Homo sapiens	IC50	nM	20000.0
	14549811	CHEMBL3226113	Inhibition of MRCK-alpha (unknown origin) using LCB-AKRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay	B	COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1O[C@H]1CCN(C)C1)CO2		CHEMBL3221813	=	IC50	nM	294.0	CHEMBL4516	Homo sapiens	IC50	nM	294.0
Not Determined	14549812	CHEMBL3226113	Inhibition of MRCK-alpha (unknown origin) using LCB-AKRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay	B	COc1ccc2c(c1)C[C@@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1O[C@H]1CCN(C)C1)CO2		CHEMBL3221814		IC50			CHEMBL4516	Homo sapiens	IC50		
	14549813	CHEMBL3226113	Inhibition of MRCK-alpha (unknown origin) using LCB-AKRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay	B	COc1ccc2c(c1)C[C@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCCO)CO2		CHEMBL3221815	=	IC50	nM	74.0	CHEMBL4516	Homo sapiens	IC50	nM	74.0
Not Determined	14549814	CHEMBL3226113	Inhibition of MRCK-alpha (unknown origin) using LCB-AKRRRLSSLRA-NH2 as substrate after 75 mins by luminescence assay	B	COc1ccc2c(c1)C[C@@H](C(=O)Nc1ccc(-c3cn[nH]c3)cc1OCCCO)CO2		CHEMBL3221816		IC50			CHEMBL4516	Homo sapiens	IC50		
	14582556	CHEMBL3241620	Inhibition of human MRCKalpha assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	127.0	CHEMBL4516	Homo sapiens	Activity	%	127.0
	14984393	CHEMBL3384982	Inhibition of MRCKA (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	56.0	CHEMBL4516	Homo sapiens	INH	%	56.0
	14984459	CHEMBL3381888	Inhibition of MRCKA (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	18.0	CHEMBL4516	Homo sapiens	INH	%	18.0
	15018640	CHEMBL3361532	Inhibition of MRCK alpha (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	-4.3	CHEMBL4516	Homo sapiens	INH	%	-4.3
	15650174	CHEMBL3595494	Inhibition of human MRCKA at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	0.0	CHEMBL4516	Homo sapiens	INH	%	0.0
	15756905	CHEMBL3631451	Inhibition of MRCKalpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	30.49	CHEMBL4516	Homo sapiens	INH	%	30.49
	15757818	CHEMBL3631451	Inhibition of MRCKalpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	12.98	CHEMBL4516	Homo sapiens	INH	%	12.98
	15758797	CHEMBL3631451	Inhibition of MRCKalpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	8.76	CHEMBL4516	Homo sapiens	INH	%	8.76
	16388288	CHEMBL3738901	Inhibition of MRCKalpha (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	Inhibition	%	-8.0	CHEMBL4516	Homo sapiens	INH	%	-8.0
	16413419	CHEMBL3743725	Inhibition of CDC42BPA (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL4516	Homo sapiens	IC50	uM	10.0
	16425247	CHEMBL3751276	Inhibition of MRCK alpha (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-4.5	CHEMBL4516	Homo sapiens	INH	%	-4.5
	16431913	CHEMBL3748006	Inhibition of human MRCKalpha using [KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4516	Homo sapiens	IC50	uM	10.0
	16451520	CHEMBL3760643	Inhibition of MRCKalpha (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	1.9	CHEMBL4516	Homo sapiens	INH	%	1.9
	16495136	CHEMBL3777499	Inhibition of MRCKalpha (unknown origin) assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	0.0	CHEMBL4516	Homo sapiens	Activity	%	0.0
	16496055	CHEMBL3777499	Inhibition of MRCKalpha (unknown origin) assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	1.0	CHEMBL4516	Homo sapiens	Activity	%	1.0
	16508242	CHEMBL3777499	Inhibition of MRCKalpha (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	5.0	CHEMBL4516	Homo sapiens	Activity	%	5.0
	16614547	CHEMBL3817578	Inhibition of human MRCKalpha at 1 uM using [KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-5.0	CHEMBL4516	Homo sapiens	INH	%	-5.0
	16618161	CHEMBL3817270	Inhibition of recombinant human His-tagged MRCKalpha catalytic domain (1 to 473 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	16641957	CHEMBL3826289	Inhibition of His-tagged human CDC42 BPA expressed in baculovirus system at 100 nM by Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	-3.0	CHEMBL4516	Homo sapiens	INH	%	-3.0
	16837427	CHEMBL3876077	Inhibition of human recombinant His-tagged CDC42BPA catalytic domain (1 to 473 residues) expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	10000.0	CHEMBL4516	Homo sapiens	IC50	nM	10000.0
Active	17887597	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	=	Kd	nM	10.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	10.0
Inactive	17887598	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887599	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887600	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887601	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887602	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887603	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887604	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887605	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887606	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887607	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887608	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887609	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887610	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887611	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887612	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887613	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887614	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887615	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887616	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887617	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887618	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887619	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887620	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887621	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887622	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887623	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887624	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887625	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887626	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887627	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887628	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887629	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887630	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887631	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887632	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887633	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887634	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887635	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887636	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887637	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887638	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887639	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887640	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887641	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887642	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887643	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Active	17887644	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	Kd	nM	561.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	561.0
Inactive	17887645	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Active	17887646	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	254.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	254.0
Inactive	17887647	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887648	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887649	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887650	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887651	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887652	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887653	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887654	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887655	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887656	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887657	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887658	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887659	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887660	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887661	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887662	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887663	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887664	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887665	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887666	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887667	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887668	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887669	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887670	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887671	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887672	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887673	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887674	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887675	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887676	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887677	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887678	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887679	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887680	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887681	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887682	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887683	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887684	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887685	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887686	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887687	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887688	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887689	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887690	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887691	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887692	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887693	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887694	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887695	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887696	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887697	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887698	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887699	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887700	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887701	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887702	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887703	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887704	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887705	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887706	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887707	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887708	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887709	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887710	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887711	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887712	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887713	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887714	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887715	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887716	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887717	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887718	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887719	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887720	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887721	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Active	17887722	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	14020.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	14020.0
Inactive	17887723	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887724	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887725	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887726	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887727	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887728	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887729	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887730	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887731	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887732	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887733	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887734	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887735	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887736	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887737	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887738	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887739	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887740	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887741	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887742	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887743	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887744	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887745	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887746	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887747	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887748	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887749	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887750	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887751	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887752	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887753	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887754	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887755	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887756	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887757	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887758	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887759	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887760	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887761	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887762	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887763	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887764	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887765	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887766	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887767	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887768	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887769	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887770	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887771	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887772	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887773	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887774	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887775	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887776	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887777	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887778	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887779	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887780	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887781	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887782	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887783	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887784	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887785	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887786	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887787	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887788	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887789	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887790	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887791	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887792	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887793	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887794	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887795	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887796	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887797	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887798	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887799	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887800	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887801	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887802	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887803	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887804	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887805	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887806	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887807	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887808	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887809	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887810	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887811	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887812	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887813	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Active	17887814	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	1094.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	1094.0
Inactive	17887815	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887816	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887817	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887818	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887819	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887820	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887821	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887822	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887823	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887824	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887825	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887826	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887827	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887828	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887829	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887830	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887831	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887832	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887833	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17887834	CHEMBL3991646	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4516	Homo sapiens	Kd apparent	nM	30000.0
	18114242	CHEMBL4025252	Inhibition of wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	98.0	CHEMBL4516	Homo sapiens	Activity	%	98.0
	18203776	CHEMBL4044063	Inhibition of wild-type human partial length MRCKA (L57 to V418 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	98.0	CHEMBL4516	Homo sapiens	Activity	%	98.0
	18253429	CHEMBL4054998	Inhibition of wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	74.0	CHEMBL4516	Homo sapiens	Activity	%	74.0
	18253430	CHEMBL4054998	Inhibition of wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	97.0	CHEMBL4516	Homo sapiens	Activity	%	97.0
	18282149	CHEMBL4120104	Inhibition of recombinant His-tagged human MRCKalpha expressed in baculovirus at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	0.4	CHEMBL4516	Homo sapiens	INH	%	0.4
	18282468	CHEMBL4120104	Inhibition of recombinant His-tagged human MRCKalpha expressed in baculovirus at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	4.3	CHEMBL4516	Homo sapiens	INH	%	4.3
	18431049	CHEMBL4155730	Inhibition of recombinant His-tagged human CDC42 BPA catalytic domain expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	-1.0	CHEMBL4516	Homo sapiens	INH	%	-1.0
	18440318	CHEMBL4157142	Binding affinity to wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL4516	Homo sapiens	Activity	%	100.0
	18484274	CHEMBL4185921	Binding affinity to wild-type human partial length MRCKA (L57 to V418 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	94.0	CHEMBL4516	Homo sapiens	Activity	%	94.0
	18484758	CHEMBL4185921	Binding affinity to wild-type human partial length MRCKA (L57 to V418 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL4516	Homo sapiens	Activity	%	100.0
	18507696	CHEMBL4191068	Inhibition of recombinant human MRCKalpha (1 to 473 residues) at 1 uM using KKRNRTLTV as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-3.0	CHEMBL4516	Homo sapiens	INH	%	-3.0
	18653515	CHEMBL4230146	Inhibition of MRCK-alpha (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	0.0	CHEMBL4516	Homo sapiens	INH	%	0.0
	18653516	CHEMBL4230146	Inhibition of MRCK-alpha (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	2.0	CHEMBL4516	Homo sapiens	INH	%	2.0
	18655414	CHEMBL4230821	Binding affinity to wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	80.0	CHEMBL4516	Homo sapiens	Activity	%	80.0
	18751047	CHEMBL4263865	Inhibition of MRCK-ALPHA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	3.0	CHEMBL4516	Homo sapiens	INH	%	3.0
	18751987	CHEMBL4264410	Binding affinity to wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	83.0	CHEMBL4516	Homo sapiens	Activity	%	83.0
	18858074	CHEMBL4307920	Binding affinity to wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	98.0	CHEMBL4516	Homo sapiens	Activity	%	98.0
	18892917	CHEMBL4314883	Inhibition of recombinant human MRCKalpha (1 to 473 residues) assessed as residual activity at 10 uM using KKRNRTLTV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	110.0	CHEMBL4516	Homo sapiens	Activity	%	110.0
	18919547	CHEMBL4322903	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged CDC42BPA (unknown origin) (1 to 574 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	43.0	CHEMBL4516	Homo sapiens	Kd	nM	43.0
	18919735	CHEMBL4322903	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged CDC42BPA (unknown origin) (1 to 574 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	25.0	CHEMBL4516	Homo sapiens	Kd	nM	25.0
	18938107	CHEMBL4327780	Inhibition of human MRCKalpha assessed as residual activity at 1 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	97.9	CHEMBL4516	Homo sapiens	Activity	%	97.9
	18938108	CHEMBL4327780	Inhibition of human MRCKalpha assessed as residual activity at 1 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	94.7	CHEMBL4516	Homo sapiens	Activity	%	94.7
	18938625	CHEMBL4328144	Inhibition of human MRCKalpha assessed as residual activity at 100 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4516	Homo sapiens	Activity	%	65.0
	18939005	CHEMBL4328508	Inhibition of human MRCKalpha using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.35	CHEMBL4516	Homo sapiens	IC50	10'-9M	5.35
	18958762	CHEMBL4333507	Binding affinity to wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	87.0	CHEMBL4516	Homo sapiens	Activity	%	87.0
	18964483	CHEMBL4335181	Inhibition of recombinant human MRCKalpha (1 to 473 residues) assessed as residual activity at 1 uM using KKRNRTLTV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	103.0	CHEMBL4516	Homo sapiens	Activity	%	103.0
	18964484	CHEMBL4335181	Inhibition of recombinant human MRCKalpha (1 to 473 residues) assessed as residual activity at 1 uM using KKRNRTLTV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	98.0	CHEMBL4516	Homo sapiens	Activity	%	98.0
	18971996	CHEMBL4337006	Inhibition of recombinant human MRCKalpha (1 to 473 residues) assessed as residual activity at 10 uM using KKRNRTLTV as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	105.0	CHEMBL4516	Homo sapiens	Activity	%	105.0
Not Active	19039684	CHEMBL4351958	Inhibition of recombinant human MRCKalpha (1 to 473 residues) at 10 uM using KKRNRTLTV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4516	Homo sapiens	INH		
Active	19041191	CHEMBL4352452	Inhibition of human MRCKalpha at 10 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4516	Homo sapiens	INH		
	19059698	CHEMBL4357999	Binding affinity to wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4516	Homo sapiens	Activity	%	100.0
	19090263	CHEMBL4365837	Inhibition of wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL4516	Homo sapiens	Activity	%	100.0
	19092018	CHEMBL4366492	Inhibition of human MRCKalpha at 100 nM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-4.25	CHEMBL4516	Homo sapiens	INH	%	-4.25
	19144658	CHEMBL4377674	Inhibition of recombinant human MRCKalpha (1 to 473 residues) at 1 uM using KKRNRTLTV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	-5.0	CHEMBL4516	Homo sapiens	INH	%	-5.0
	19147943	CHEMBL4379261	Inhibition of recombinant human MRCKalpha (1 to 473 residues) using KKRNRTLTV as substrate incubated for 40 mins in presence of [gamma-33ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4516	Homo sapiens	IC50	uM	10.0
	19159526	CHEMBL4382630	Binding affinity to wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	97.0	CHEMBL4516	Homo sapiens	Activity	%	97.0
	19181086	CHEMBL4387297	Inhibition of recombinant human His-tagged MRCKalpha catalytic domain (1 to 473 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-13 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	31.5	CHEMBL4516	Homo sapiens	INH	%	31.5
	19181311	CHEMBL4387297	Inhibition of recombinant human His-tagged MRCKalpha catalytic domain (1 to 473 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-13 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	1.0	CHEMBL4516	Homo sapiens	INH	%	1.0
	19191481	CHEMBL4389349	Inhibition of wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL4516	Homo sapiens	INH	%	100.0
	19192012	CHEMBL4389826	Inhibition of wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL4516	Homo sapiens	INH	%	100.0
	19200268	CHEMBL4391452	Binding affinity to wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	97.0	CHEMBL4516	Homo sapiens	Activity	%	97.0
	19266514	CHEMBL4405464	Inhibition of wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4516	Homo sapiens	INH	%	50.0
	19276050	CHEMBL4408053	Inhibition of recombinant human MRCKalpha (1 to 473 residues) at 1 uM using KKRNRTLTV as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	21.0	CHEMBL4516	Homo sapiens	INH	%	21.0
	19476554	CHEMBL4479702	Inhibition of recombinant human His-tagged CDC42BPA catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	1200.0	CHEMBL4516	Homo sapiens	IC50	nM	1200.0
	19476654	CHEMBL4479702	Inhibition of recombinant human His-tagged CDC42BPA catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	9200.0	CHEMBL4516	Homo sapiens	IC50	nM	9200.0
	19476754	CHEMBL4479702	Inhibition of recombinant human His-tagged CDC42BPA catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	72.0	CHEMBL4516	Homo sapiens	IC50	nM	72.0
	19476854	CHEMBL4479702	Inhibition of recombinant human His-tagged CDC42BPA catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	1000.0	CHEMBL4516	Homo sapiens	IC50	nM	1000.0
	20600479	CHEMBL4603270	Inhibition of recombinant human His-tagged MRCKalpha catalytic domain (1 to 473 residues) expressed in baculovirus expression system using serine/threonine-13 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4516	Homo sapiens	IC50	uM	100.0
	22392105	CHEMBL4667200	Inhibition of recombinant human His-tagged MRCKA (1 to 473 residues) expressed in baculovirus expression system using Ser/Thr 13 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	0.0	CHEMBL4516	Homo sapiens	INH	%	0.0
	22423437	CHEMBL4674294	Inhibition of human MRCKalpha using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	96.7	CHEMBL4516	Homo sapiens	Activity	%	96.7
	22423438	CHEMBL4674294	Inhibition of human MRCKalpha using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	99.77	CHEMBL4516	Homo sapiens	Activity	%	99.77
	22843659	CHEMBL4720645	Inhibition of human MRCKalpha using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.998	CHEMBL4516	Homo sapiens	IC50	10^-10M	9.98
	22844008	CHEMBL4720994	Inhibition of human MRCKalpha assessed as residual activity using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	105.66	CHEMBL4516	Homo sapiens	Activity	%	105.66
	22844762	CHEMBL4721437	Inhibition of wild-type human partial length MRCKA (L57 to V418 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	99.4	CHEMBL4516	Homo sapiens	Activity	%	99.4
	22952911	CHEMBL4766848	Inhibition of recombinant human MRCKalpha (1 to 473 residues) assessed as residual activity at 10 uM using KKRNRTLTV as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	105.0	CHEMBL4516	Homo sapiens	Activity	%	105.0
	23122683	CHEMBL4805034	Inhibition of human MRCKA assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	98.0	CHEMBL4516	Homo sapiens	Activity	%	98.0
	23123378	CHEMBL4805622	Inhibition of human MRCKA assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL4516	Homo sapiens	Activity	%	100.0
	23123837	CHEMBL4806081	Inhibition of DNA-tagged human MRCKA assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	92.0	CHEMBL4516	Homo sapiens	Activity	%	92.0
	23124846	CHEMBL4806639	Inhibition of human MRCKA assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	94.0	CHEMBL4516	Homo sapiens	Activity	%	94.0
	23124847	CHEMBL4806639	Inhibition of human MRCKA assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4516	Homo sapiens	Activity	%	100.0
	23127879	CHEMBL4807768	Inhibition of CDC42BPA (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	50.0	CHEMBL4516	Homo sapiens	Activity	%	50.0
	23127880	CHEMBL4807768	Inhibition of CDC42BPA (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4516	Homo sapiens	Activity	%	75.0
	23127881	CHEMBL4807768	Inhibition of CDC42BPA (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4516	Homo sapiens	Activity	%	75.0
Not Active	23317519	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23317987	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23318654	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	78.0	CHEMBL4516	Homo sapiens	% Control	%	78.0
Not Active	23319137	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	81.0	CHEMBL4516	Homo sapiens	% Control	%	81.0
Not Active	23319774	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23320249	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	96.6	CHEMBL4516	Homo sapiens	% Control	%	96.6
Not Active	23320927	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23321395	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23322025	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	94.0	CHEMBL4516	Homo sapiens	% Control	%	94.0
Not Active	23322493	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	90.0	CHEMBL4516	Homo sapiens	% Control	%	90.0
Not Active	23323182	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	90.0	CHEMBL4516	Homo sapiens	% Control	%	90.0
Not Active	23323650	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23324065	CHEMBL4880684	MRCKalpha (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-10.0	CHEMBL4516	Homo sapiens	% inhibition	%	-10.0
Not Active	23324504	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	82.2	CHEMBL4516	Homo sapiens	% Control	%	82.2
Not Active	23325139	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23325607	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	91.0	CHEMBL4516	Homo sapiens	% Control	%	91.0
Not Active	23326254	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	91.0	CHEMBL4516	Homo sapiens	% Control	%	91.0
Not Active	23326722	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	95.0	CHEMBL4516	Homo sapiens	% Control	%	95.0
Not Active	23327422	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23327890	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23328477	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	97.0	CHEMBL4516	Homo sapiens	% Control	%	97.0
Not Active	23328945	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23329429	CHEMBL4881136	MRCKalpha (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	111.0	CHEMBL4516	Homo sapiens	% residual kinase activity	%	111.0
Not Active	23329891	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23330359	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	99.0	CHEMBL4516	Homo sapiens	% Control	%	99.0
Not Active	23331115	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23331583	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23332170	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23332636	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	88.5	CHEMBL4516	Homo sapiens	% Control	%	88.5
Not Active	23333354	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23333993	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	67.0	CHEMBL4516	Homo sapiens	% Control	%	67.0
Not Active	23334461	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	92.0	CHEMBL4516	Homo sapiens	% Control	%	92.0
Not Active	23335440	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	98.0	CHEMBL4516	Homo sapiens	% Control	%	98.0
Not Active	23335908	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	84.0	CHEMBL4516	Homo sapiens	% Control	%	84.0
Not Active	23336535	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23337003	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23337535	CHEMBL4881906	CDC42 BPA Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	102.0	CHEMBL4516	Homo sapiens	% Ctrl	%	102.0
Not Active	23338084	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23338552	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23339164	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	89.0	CHEMBL4516	Homo sapiens	% Control	%	89.0
Not Active	23339632	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23340269	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23340737	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23341394	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23341862	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23342478	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	87.0	CHEMBL4516	Homo sapiens	% Control	%	87.0
Not Active	23342946	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23343576	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23344044	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	79.0	CHEMBL4516	Homo sapiens	% Control	%	79.0
Not Active	23344682	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23345255	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23345723	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	87.0	CHEMBL4516	Homo sapiens	% Control	%	87.0
Not Active	23346300	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	86.2	CHEMBL4516	Homo sapiens	% Control	%	86.2
Not Active	23346768	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23347370	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	86.5	CHEMBL4516	Homo sapiens	% Control	%	86.5
Not Active	23347860	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	93.5	CHEMBL4516	Homo sapiens	% Control	%	93.5
Not Active	23348439	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23348907	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	95.0	CHEMBL4516	Homo sapiens	% Control	%	95.0
Not Active	23349494	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	91.0	CHEMBL4516	Homo sapiens	% Control	%	91.0
Not Active	23350112	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23350580	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23351185	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23351653	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23351984	CHEMBL4882677	CDC42 BPA (MRCKA) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	2.462	CHEMBL4516	Homo sapiens	% Inhibition	%	2.4616
Not Active	23352677	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	90.0	CHEMBL4516	Homo sapiens	% Control	%	90.0
Not Active	23353145	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	89.0	CHEMBL4516	Homo sapiens	% Control	%	89.0
Not Active	23354027	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23354495	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23355227	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23355695	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23356331	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23356799	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23357408	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23358055	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	95.0	CHEMBL4516	Homo sapiens	% Control	%	95.0
Not Active	23358523	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23359109	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23359707	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23360175	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23360760	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23361228	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23361801	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23362337	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23362805	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	81.0	CHEMBL4516	Homo sapiens	% Control	%	81.0
Not Active	23364447	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	56.0	CHEMBL4516	Homo sapiens	% Control	%	56.0
Not Active	23364915	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	96.0	CHEMBL4516	Homo sapiens	% Control	%	96.0
Not Active	23365654	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	97.0	CHEMBL4516	Homo sapiens	% Control	%	97.0
Not Active	23366197	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23366787	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23367255	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23367493	CHEMBL4883846	CDC42BPA ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	98.0	CHEMBL4516	Homo sapiens	% Residual activity with Skepinone-L	%	98.0
Not Active	23368133	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	96.0	CHEMBL4516	Homo sapiens	% Control	%	96.0
Not Active	23368601	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	94.0	CHEMBL4516	Homo sapiens	% Control	%	94.0
Not Active	23369200	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	99.0	CHEMBL4516	Homo sapiens	% Control	%	99.0
Not Active	23369668	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23370147	CHEMBL4884391	MRCKalpha(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	98.0	CHEMBL4516	Homo sapiens	% residual kinase activity	%	98.0
Not Active	23370636	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23371104	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23371913	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23372381	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
	23372677	CHEMBL4884642	MRCKalpha(CD4ALGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4516	Homo sapiens	pIC50		6.0
	23373086	CHEMBL4884933	MRCKalpha(CD4ALGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4516	Homo sapiens	pIC50		6.0
	23373447	CHEMBL4885224	MRCKalpha(CD4ALGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4516	Homo sapiens	pIC50		6.0
Not Active	23375039	CHEMBL4886028	MRCK_alpha Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	1.5	CHEMBL4516	Homo sapiens	% Inhibition	%	1.5
Not Active	23375808	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	91.0	CHEMBL4516	Homo sapiens	% Control	%	91.0
Not Active	23376276	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23376853	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	91.0	CHEMBL4516	Homo sapiens	% Control	%	91.0
Not Active	23377321	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	84.0	CHEMBL4516	Homo sapiens	% Control	%	84.0
Not Active	23378181	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23378649	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	98.0	CHEMBL4516	Homo sapiens	% Control	%	98.0
Not Active	23379816	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23380284	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	84.0	CHEMBL4516	Homo sapiens	% Control	%	84.0
Not Active	23380978	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23381626	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23382094	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4516	Homo sapiens	% Control	%	100.0
Not Active	23382718	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	98.0	CHEMBL4516	Homo sapiens	% Control	%	98.0
Not Active	23383186	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	80.0	CHEMBL4516	Homo sapiens	% Control	%	80.0
Not Active	23383723	CHEMBL4887372	CDC42 BPA Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	95.0	CHEMBL4516	Homo sapiens	% Ctrl	%	95.0
Not Active	23384358	CHEMBL4887953	MRCKalpha(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-4.99	CHEMBL4516	Homo sapiens	% inhibition	%	-4.99
Not Active	23384640	CHEMBL4888166	CDC42 BPA (MRCKA) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	2.0	CHEMBL4516	Homo sapiens	% Inhibition	%	2.0
Not Active	23385101	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	86.0	CHEMBL4516	Homo sapiens	% Control	%	86.0
Not Active	23385568	CHEMBL4879825	KinomeScan assay: inhibition of MRCKA	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	94.0	CHEMBL4516	Homo sapiens	% Control	%	94.0
